Archive for February, 2010

NetSol Technologies, Inc. (NTWK) Announces Q2 FY 2010 Financial Results

NetSol Technologies, Inc., a U.S. corporation providing global business services and enterprise application solutions to private and public sector organizations worldwide, today reported its second quarter financial results for fiscal year 2010, for the period ended December 31, 2009.

Financial highlights for the quarter include:

• $9.5 million in revenues, up 81% year-over-year and 25% sequentially
• Substantial improvement in gross margin to 62% compared to 27% a year earlier
• Operating income of $1.7 million compared to an operating loss of $2.8 million in the same period a year ago
• GAAP net loss applicable to common shareholders of only $0.4 million compared to GAAP net loss of $3.3 million in the year ago period
• EBITDA totaled $0.9 million, or $0.03 per diluted share, versus an EBITDA loss of $1.9 million, or a loss of $0.07 per diluted share, in the same period a year ago

In the press release, NetSol reiterated its guidance for fiscal year 2010 projecting revenues in the range of $33.0 million and $35.0 million, representing full year revenue growth of between 25% and 32% when compared to fiscal year 2009. The company also anticipates a return to GAAP net income for fiscal year 2010, versus a GAAP net loss of $0.30 per diluted share for fiscal year 2009. License revenues for fiscal year 2010 are expected to increase more than 100% versus fiscal year 2009.

Najeeb Ghauri, NetSol Technologies chairman and chief executive officer, stated, “Our fiscal second quarter 2010 financial results marked our third consecutive quarter of double-digit sequential revenue growth, highlighted by an 81% increase in sales versus the year ago period. NetSol also delivered material improvements in gross margin, operating income, GAAP net income, and EBITDA results versus the year ago period. These performance gains highlight the significant improvement in NetSol’s core business as we continue to successfully convert our business pipeline to customer wins.”

He added, “Revenues from license fees resumed a pre-recession trajectory growing over 400% year-over-year as global customers began to further unlock spending and resume the purchase of large strategic software solutions, particularly in the automotive and financial sectors. Additionally, we continue to implement efficiency measures aimed at increasing our long-term profitability. Our efforts to continuously rationalize operating expenses included the relocation of our global and operating headquarters in the U.S., now under the leadership of Mr. Imran Haider, the recently appointed Chief Operating Officer of NetSol North America, Inc., to Alameda which is expected to save the company an estimated $5 million over a 5 year period.”

“As NetSol continued to invest in its core NetSol Financial Suite (NFS)(TM) throughout the global economic downturn the company is well positioned to leverage the upturn in customer activity we continue to see, particularly in China, as NetSol begins the second half of its fiscal year 2010 with continued positive momentum. We are continuing to see increased interest among major customers as well as potential partners in the sector and see excellent opportunities for collaboration and strategic initiatives as we look ahead to the second half of our fiscal year 2010,” concluded Mr. Ghauri.

Business highlights for the quarter include:

• Relocation of global and U.S. operating headquarters which will save approximately $5 million over a five year period
• Appointment of Mr. Imran Haider as the new Chief Operating Officer of NetSol North America, Inc. bringing 8 years of product and sales expertise from NetSol Asia Pacific
• Toyota Motor Finance China upgrades to a NetSol Financial Suite(TM) license
• A major Chinese automotive finance company awarded NetSol a $2 million contract
• Expanded sales and delivery capabilities in China, leveraging fast growing Chinese consumer and asset finance market
• NetSol secured a major Information Security contract in the mobile telecommunications sector
• BMW Group Financial Services awarded NetSol additional services contract
• NetSol awarded IT Services contract in Saudi Arabia, further expanding presence in the Middle East market
• United Kingdom based bank awarded NetSol a $1 million major software and IT services contract
• NetSol IT Business Services awarded Information Security contract to implement a data center security project in conjunction with a leading solution integrator in Pakistan

Monday, February 8th, 2010 Uncategorized Comments Off on NetSol Technologies, Inc. (NTWK) Announces Q2 FY 2010 Financial Results

Ableauctions (AAC) Acquires Coal and Coke Producer SinoCoking

Feb. 4, 2010 (Business Wire) — Ableauctions.com Inc. (AMEX:AAC) (the “Company”) released a statement today about its acquisition of SinoCoking, a coal and coke producer based in central China.

“We are pleased to announce our acquisition of SinoCoking, a coal and coke producer based in the Henan Province in the People’s Republic of China,” said Abdul Ladha, Chief Executive Officer of Ableauctions.com, Inc. The closing of the acquisition is scheduled to occur at the close of business on February 5, 2010. Mr. Ladha further added “this acquisition has provided our shareholders with a unique opportunity to participate as equity holders in what we believe to be a company that has good fundamentals and growth potential as a supplier of products of vital economic importance within China’s fast-growing economy. Moreover, the transaction allows our pre-acquisition shareholders to receive the full liquidation value of our pre-acquisition business assets in addition to a 3% aggregate stake in the reorganized company to be renamed SinoCoking Coal and Coke Chemical Industries, Inc. We are excited about the potential of SinoCoking to grow and build shareholder value.”

Mr. Ladha, who has served as Chief Executive Officer of Ableauctions since 1999, will step down as CEO on February 5, and will be succeeded by Mr. Jianhua Lv, who is an initial founder and current President of SinoCoking. In addition, on February 5, 2010, the current board of directors of Ableauctions will step down and be succeeded by seven new directors designated by SinoCoking.

Mr. Jianhua Lv, the incoming CEO of the Company stated “As a coal producer and coke manufacturer, SinoCoking has been a significant supplier of the vital commodities of thermal and metallurgical coal and coke to industrial customers such as power plants, steel mills and other industrial buyers in China since 1996. SinoCoking is a vertically-integrated processor that uses coal from both its own mines and that of third-party mines to provide basic and value-added coal products to its client base. SinoCoking currently holds mining rights for approximately 2.5 million tons of coal from mines located in central China. SinoCoking began producing metallurgical coke in 2002, and since then has expanded its production to become an important supplier to regional steel producers in central China. Coke, which is an essential ingredient in steel-making, is manufactured in SinoCoking’s on-site facilities by heating selected coal with certain thermal and chemical properties at extremely high temperatures in an oxygen-free environment. For the year ending June 30, 2009, SinoCoking produced and sold 154,631 tons of coke, 55,360 tons of washed coal, and 72,923 tons of raw coal, and generated $51 million in revenue from sales consisting primarily of these products. During its 2009 fiscal year, SinoCoking had audited net income of approximately $17 million on a GAAP basis.”

Mr. Lv went on to say “We produce essential products that power the industrial growth of China – coal and coke, and we see this moment as only the beginning of a long-term secular expansion. Currently, the demand from our customers significantly exceeds our current production capacity, and we think that demand from Chinese industrial purchasers will continue to increase. We are investing heavily in building our production capacity, and since we are a larger producer that utilizes advanced manufacturing processes with less impact on the environment, we enjoy strong support from the Henan provincial and local governments.

Although the Chinese government has recently taken steps to slow its rapid economic expansion, the Chinese economy is nonetheless expected to grow at an annual rate of approximately 9% per year for the next five years, according to government sources. Domestic steel demand is expected to grow at 10% per year over the same period. China’s demand for coke is expected to be approximately 4.5 billion tons per year in the following years, and as a nation it is now the largest producer and consumer of coking coal in the world. As a source of fuel, approximately 70% of China’s energy consumption is derived from coal, and as such it is regarded as key element of China’s energy policy and strategy. The Chinese government has also engaged in a policy of promoting consolidation within the coal mining industry, as larger operators have been determined to operate more efficiently, with consistently higher safety records and less environmental impact.”

“Coal and coke are fundamentally important products to the growth of China. We believe that SinoCoking can mine, produce, market and fulfill these products more effectively than many of our competitors. We also believe that right now, there is no better market in the world to operate and grow our business than China,” said Mr. Lv. “On behalf of SinoCoking, we are proud to complete this business combination with a U.S. publicly-traded company. Being a U.S. public company will put us in a position to attract the capital that our company needs to expand our operations, and create value for our shareholders.”

About SinoCoking

Top Favour Limited, a British Virgin Islands holding company (“Top Favour”), through its wholly owned subsidiary Pingdingshan Hongyuan Energy Science and Technology Development Co., Ltd. (“Hongyuan”), controls Henan Province Pingdingshan Hongli Coal & Coke Co., Ltd. (“Hongli”), a coal and coal-coke producer in Henan Province in the central region of the People’s Republic of China (“PRC” or “China”). Hongli produces coke, coal, coal byproducts and electricity through its branch operation, Baofeng Coking Factory, and its wholly owned subsidiaries, Baofeng Hongchang Coal Co., Ltd. and Baofeng Hongguang Environment Protection Electricity Generating Co., Ltd. (collectively referred to as “SinoCoking”).

For further information about SinoCoking, please refer to the Definitive Proxy Statement of Ableauctions.com, Inc. filed on Schedule 14A with the Securities and Exchange Commission on November 27, 2009.

For a comprehensive Corporate Update and prior releases, visit www.ableauctions.com. For more information, contact Investor Relations at investorrelations@ableauctions.com

This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company’s financial position, the Company’s business strategy, the Company’s real estate development project, including the business of SinoCoking. The words or phrases “would be,” “will allow,” “intends to,” “may result,” “are expected to,” “will continue,” “anticipates,” “expects,” “estimate,” “project,” “indicate,” “could,” “potentially,” “should,” “believe,” “think”, “considers” or similar expressions are intended to identify “forward-looking statements.” These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the global recession, the performance of our staff and management, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our Annual Report on Form 10-K and on documents we file from time-to-time with the Securities and Exchange Commission. Factors that could cause our real estate development results to differ materials from anticipated results include delay experienced during any phase of the project development (such as in obtaining permits) or unforeseen problems (such as labor disputes, increasing materials costs, or an inability to obtain adequate financing). Even if we are able to build the project, the market for the units we build could decline. We cannot guarantee you that our building projects will be successful or that we will be able to recover the money we put into them. If our building projects are unsuccessful, our business and our cash flow will be materially adversely affected. Price changes may occur in the market as a whole, or they may occur in only a particular company, industry, or sector of the market. Real estate values and mortgage loans can be seriously affected by factors such as interest rate fluctuations, bank liquidity, the availability of financing, and by factors such as a zoning change or an increase in property taxes. Since the majority of our investments are held in Canadian funds, currency fluctuations may affect the value of our portfolio significantly. There can be no assurance that the securities and other assets in which we have invested will increase, or even maintain, their value. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place undue reliance on such statements. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company’s expectations and estimates.

Friday, February 5th, 2010 Uncategorized Comments Off on Ableauctions (AAC) Acquires Coal and Coke Producer SinoCoking

China Agritech, Inc. (CAGC) Announces 2 for 1 Forward Stock Split Effective February 1, 2010

Feb. 5, 2010 (PR Newswire) — China Agritech, Inc. Announces 2 for 1 Forward Stock Split Effective February 1, 2010

BEIJING — China Agritech, Inc. (Nasdaq: CAGC) (“China Agritech” or “the Company”), a leading national organic fertilizer manufacturer and distributor in China, today announced that it effected a 2 for 1 forward split of its common stock on February 1, 2010 which will be reflected on NASDAQ beginning with trading on Monday, February 8, 2010.

The effect of the forward split will be to increase the number of shares of common stock outstanding to approximately 17.3 million from the 8.7 million shares outstanding prior to the forward split. Each shareholder of record as of the close of trading on February 1, 2010, will have 2 common shares for every 1 common share previously held.

Mr. Yu Chang, Chief Executive Officer of China Agritech, commented, “We believe the Company’s shareholders will benefit from the greater liquidity in the Company’s common stock created by the stock split. The success of our strategic plan through the introduction of our new organic granular fertilizers combined with our organic liquid fertilizers, has generated increased financial results and shareholder interest. The greater liquidity may make the stock more attractive for certain institutions and improve our trading characteristics.”

About China Agritech, Inc.

China Agritech, Inc. is engaged in the development, manufacture and distribution of liquid and granular organic compound fertilizers and related products in China. The Company has developed proprietary formulas that provide a continuous supply of high-quality agricultural products while maintaining soil fertility. The Company sells its products to farmers located in 28 provinces of China.

For more information about the Company, please visit http://www.chinaagritechinc.com.

Safe Harbor Statement

This release may contain certain “forward-looking statements” relating to the business of China Agritech and its subsidiary companies, which can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions, including, but not limited to, statements regarding the continued demand for China Agritech’s products, China Agritech’s ability to sustain growth for the balance of the year and China Agritech’s ability to generally meet all of its objectives. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, concentration in a single customer, raw material costs, market acceptance, future capital requirements, and competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the SEC. Except as required by law, China Agritech is under no obligation to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Friday, February 5th, 2010 Uncategorized Comments Off on China Agritech, Inc. (CAGC) Announces 2 for 1 Forward Stock Split Effective February 1, 2010

Benefits of CyberKnife Radiosurgery for Lung Cancer Drive Continued Adoption

Feb. 5, 2010 (PR Newswire) — Benefits of CyberKnife Radiosurgery for Lung Cancer Drive Continued Adoption

SUNNYVALE, Calif. — Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009.

CyberKnife radiosurgery offers lung cancer patients a non-invasive means for treating their disease. The outpatient treatment is completed in five or fewer visits, and is both painless and non-surgical. Because the CyberKnife System utilizes continual image guidance along with continual correction for respiratory motion, it is able to deliver high-doses of radiation to the tumor from hundreds of angles with pinpoint precision.

Judith, a lung cancer survivor, shares her experience having been treated with both conventional lung cancer treatments and CyberKnife radiosurgery:

Judith was diagnosed with stage IIIa lung cancer in the winter of 2004. At that time she received 12 rounds chemotherapy, 23 days of radiation therapy and surgery two weeks later to remove the upper lobe of her right lung. Recovery from her treatment was difficult, involving a 15 day hospital stay and four weeks of recovery at home. During a follow-up visit, some residual cancer was discovered leading her to undergo eight more rounds of chemotherapy. Judith hoped the worst of things were behind her and for almost three years they were.

Then in the summer of 2007 doctors found a recurrence of her cancer in a lymph node located deep in the center of Judith’s chest. Since she had already undergone surgery and had received conventional radiation years prior and given the location of the cancer close to sensitive, vital structures in her chest, her thoracic surgeon suggested CyberKnife radiosurgery. Because of its extreme precision, the CyberKnife System is able to focus the radiation delivery on the tumor and avoid surrounding healthy tissue, meaning Judith was a candidate despite having previous radiation. Judith’s CyberKnife treatment was completed in four outpatient sessions. She was able to resume her daily activities after each treatment and got back to work right away. Nearly three years later Judith is doing well and has had no recurrences.

“The first time round, it was an eight month period of my life spent at the cancer center, so the second time, when I had the option to do four treatments over two weeks and be done, it was a no brainer,” said Judith. “With the CyberKnife there was no downtime and I didn’t experience any side effects. During the treatments I just lay comfortably on the treatment table and was able to watch the animal channel on a TV in the ceiling. It was a piece of cake compared to what I had been through already.”

To view a brief interview with Judith, please visit: http://www.youtube.com/cyberknifeckcam.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world’s only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to deliver more than 80,000 treatments worldwide and currently 190 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to clinical studies, regulatory review and approval, and commercialization of products are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading “Risk Factors” in our report on Form 10-K for the 2009 fiscal year, our quarterly report on Form 10-Q filed on February 4, 2010 and our other filings with the Securities and Exchange Commission. The Company’s actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Friday, February 5th, 2010 Uncategorized Comments Off on Benefits of CyberKnife Radiosurgery for Lung Cancer Drive Continued Adoption

Kelly Services (KELYA) Reports 4th Quarter 2009 and Year-End Results

TROY, MI, Feb. 5, 2010 (Marketwire) —

TROY, MI — (Marketwire) — 02/05/10 — Kelly Services, Inc. (NASDAQ: KELYA) (NASDAQ: KELYB), a world leader in workforce solutions, today announced results for the fourth quarter and year ended January 3, 2010.

Carl T. Camden, President and Chief Executive Officer, announced revenue for the fourth quarter of 2009 totaled $1.2 billion, a 7% decrease compared to the corresponding quarter in 2008. On a sequential basis, fourth quarter revenue increased 14%, compared to the third quarter in 2009. Revenue for the full year totaled $4.3 billion, a 22% decrease compared to the prior year. The fourth quarter included an extra week which adds approximately 4-5% to our quarterly comparisons and 1% to annual comparisons.

Losses from operations for the fourth quarter of 2009 totaled $13.0 million, compared to losses from operations of $83.7 million reported for the fourth quarter of 2008. Included in the results from operations for the fourth quarter of 2009 are restructuring charges of $13.4 million. The loss from operations in the fourth quarter of 2008 included impairment charges of $80.5 million and restructuring charges of $4.3 million. Excluding the impairment and restructuring charges, earnings from operations were $0.4 million in the fourth quarter of 2009 compared to $1.1 million in 2008.

Losses from operations for the full year of 2009 totaled $146.1 million compared to a loss of $70.3 million in 2008. The results for the full year 2009 include $53.1 million of impairment charges, $5.3 million of legal charges and $29.9 million of restructuring charges. The results for 2008 included $80.5 million of impairment charges, $22.5 million of legal charges and $6.5 million of restructuring charges.

Diluted losses per share from continuing operations in the fourth quarter of 2009 were $0.23 compared to fourth quarter 2008 losses of $2.55 per share. The restructuring charges totaled $0.29 per share in the fourth quarter of 2009. The impairment charges were $2.22 per share and the restructuring charges were $0.11 per share in the fourth quarter of 2008.

Diluted losses per share from continuing operations for the full year of 2009 were $3.01 compared to 2008 losses of $2.35 per share. The impairment charges totaled $1.43 per share, legal charges totaled $0.09 per share and restructuring charges totaled $0.69 per share in 2009. The impairment charges were $2.22 per share, legal charges were $0.40 per share and the restructuring charges were $0.15 per share in 2008.

Commenting on the fourth quarter results, Camden was optimistic. “We are very pleased that the improved revenue trends in our business, combined with our significant cost reduction initiatives allowed us to realize a small operating profit for the fourth quarter, excluding restructuring charges.”

Camden added that while 2009 has been a challenging year for the staffing industry, “Kelly has done an excellent job of re-shaping and strategically positioning the company to seize future growth opportunities and create value for our shareholders.

“We look forward to 2010, and will focus on maximizing profitability across all operations; accelerating growth of higher-margin Professional & Technical disciplines and outsourcing and consulting services; winning new business; and helping our customers manage their ever-changing workforce needs.”

In conjunction with its fourth quarter earnings release, Kelly Services, Inc. will host a conference call at 9:00 a.m. (ET) on February 5, to review the results and answer questions. The call may be accessed in one of the following ways:

Via the Telephone:

U.S. 1 800 288-9626International 1 612 332-0107

The pass code is Kelly Services

Via the Internet:

The call is also available via the internet through the Kelly Services website: www.kellyservices.com

This release contains statements that are forward looking in nature and accordingly, are subject to risks and uncertainties. These factors include: competition, changing market and economic conditions, currency fluctuations, changes in laws and regulations, including tax laws, and other factors discussed in this release and in the Company’s filings with the Securities and Exchange Commission. Actual results may differ materially from any forward-looking statements contained herein.

About Kelly Services

Kelly Services, Inc. (NASDAQ: KELYA) (NASDAQ: KELYB) is a leader in providing workforce solutions. Kelly offers a comprehensive array of outsourcing and consulting services as well as world-class staffing on a temporary, temp-to-hire and permanent placement basis. Serving clients around the globe, Kelly provides employment to 480,000 employees annually. Revenue in 2009 was $4.3 billion. Visit www.kellyservices.com.

KELLY SERVICES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGSFOR THE 14 WEEKS ENDED JANUARY 3, 2010 AND 13 WEEKS ENDED DECEMBER 28, 2008 (UNAUDITED) (In millions of dollars except per share data) 2009 2008 Change % Change ——— ——— ——— ——–Revenue from services $ 1,194.1 $ 1,279.1 $ (85.0) (6.6)%Cost of services 1,005.8 1,054.5 (48.7) (4.6) ——— ——— ——— ——–Gross profit 188.3 224.6 (36.3) (16.2)Selling, general and administrative expenses 201.3 227.8 (26.5) (11.7)Asset impairments – 80.5 (80.5) (100.0) ——— ——— ——— ——–Loss from operations (13.0) (83.7) 70.7 84.5Other expense, net (0.9) (3.4) 2.5 73.8 ——— ——— ——— ——–Loss from continuing operations before taxes (13.9) (87.1) 73.2 84.1Income taxes (5.7) 1.5 (7.2) (469.5) ——— ——— ——— ——–Loss from continuing operations (8.2) (88.6) 80.4 90.8Loss from discontinued operations, net of tax – (0.1) 0.1 100.0 ——— ——— ——— ——–Net loss $ (8.2) $ (88.7) $ 80.5 90.8 % ========= ========= ========= ========Basic loss per share on common stock Loss from continuing operations $ (0.23) $ (2.55) $ 2.32 91.0 % Loss from discontinued operations – (0.01) 0.01 100.0 Net loss (0.23) (2.55) 2.32 91.0Diluted loss per share on common stock Loss from continuing operations $ (0.23) $ (2.55) $ 2.32 91.0 % Loss from discontinued operations – (0.01) 0.01 100.0 Net loss (0.23) (2.55) 2.32 91.0 ——— ——— ——— ——–STATISTICS:Gross profit rate 15.8 % 17.6 % (1.8)pts.Selling, general and administrative expenses: % of revenue 16.8 17.8 (1.0) % of gross profit 106.9 101.4 5.5% Return – Loss from operations (1.1) (6.5) 5.4 Loss from continuing operations before taxes (1.2) (6.8) 5.6 Loss from continuing operations (0.7) (6.9) 6.2 Net loss (0.7) (6.9) 6.2Effective income tax rate 41.0 % (1.8) % 42.8 pts. KELLY SERVICES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGSFOR THE 53 WEEKS ENDED JANUARY 3, 2010 AND 52 WEEKS ENDED DECEMBER 28, 2008 (In millions of dollars except per share data) 2009 2008 Change % Change ———- ———- ———- ———Revenue from services $ 4,314.8 $ 5,517.3 $ (1,202.5) (21.8)%Cost of services 3,613.1 4,539.7 (926.6) (20.4) ———- ———- ———- ———Gross profit 701.7 977.6 (275.9) (28.2)Selling, general and administrative expenses 794.7 967.4 (172.7) (17.9)Asset impairments 53.1 80.5 (27.4) (34.1) ———- ———- ———- ———Loss from operations (146.1) (70.3) (75.8) (107.8)Other expense, net (2.2) (3.4) 1.2 35.8 ———- ———- ———- ———Loss from continuing operations before taxes (148.3) (73.7) (74.6) (101.1)Income taxes (43.2) 8.0 (51.2) NM ———- ———- ———- ———Loss from continuing operations (105.1) (81.7) (23.4) (28.6)Earnings (loss) from discontinued operations, net of tax 0.6 (0.5) 1.1 212.0 ———- ———- ———- ———Net loss $ (104.5) $ (82.2) $ (22.3) (27.0)% ========== ========== ========== =========Basic loss per share on common stock Loss from continuing operations $ (3.01) $ (2.35) $ (0.66) (28.1)% Earnings (loss) from discontinued operations 0.02 (0.02) 0.04 200.0 Net loss (3.00) (2.37) (0.63) (26.6)Diluted loss per share on common stock Loss from continuing operations $ (3.01) $ (2.35) $ (0.66) (28.1)% Earnings (loss) from discontinued operations 0.02 (0.02) 0.04 200.0 Net loss (3.00) (2.37) (0.63) (26.6) ———- ———- ———- ———STATISTICS:Gross profit rate 16.3 % 17.7 % (1.4)pts.Selling, general and administrative expenses: % of revenue 18.4 17.5 0.9 % of gross profit 113.2 99.0 14.2% Return – Loss from operations (3.4) (1.3) (2.1) Loss from continuing operations before taxes (3.4) (1.3) (2.1) Loss from continuing operations (2.4) (1.5) (0.9) Net loss (2.4) (1.5) (0.9)Effective income tax rate 29.1 % (10.8) % 39.9 pts. KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (UNAUDITED) (In millions of dollars) Fourth Quarter —————————————- Constant 2009 2008 Currency (14 Weeks)(13 Weeks) Change Change ——– ——– ———- ——-Americas Commercial Revenue from services (including fee-based income) $ 557.4 $ 595.6 (6.4)% (7.3)% Fee-based income 1.5 2.8 (46.7) (48.3) Gross profit 79.8 96.4 (17.2) (18.0) SG&A expenses excluding restructuring charges 67.9 79.7 (14.8) Restructuring charges 3.5 0.6 450.2 Total SG&A expenses 71.4 80.3 (11.1) (11.9) Earnings from operations 8.4 16.1 (47.7) Earnings from operations excluding restructuring charges 11.9 16.7 (28.9) Gross profit rate 14.3% 16.2% (1.9)pts. Expense rates (excluding restructuring charges): % of revenue 12.2 13.4 (1.2) % of gross profit 85.0 82.5 2.5 Operating margin (excluding restructuring charges) 2.2 2.8 (0.6)Americas PT Revenue from services (including fee-based income) $ 208.3 $ 219.3 (5.0)% (5.3)% Fee-based income 2.2 3.7 (39.8) (40.0) Gross profit 31.9 37.5 (14.9) (15.1) SG&A expenses excluding restructuring charges 24.7 27.8 (11.0) Restructuring charges 0.8 – NM Total SG&A expenses 25.5 27.8 (8.1) (8.3) Earnings from operations 6.4 9.7 (34.4) Earnings from operations excluding restructuring charges 7.2 9.7 (26.2) Gross profit rate 15.3% 17.1% (1.8)pts. Expense rates (excluding restructuring charges): % of revenue 11.9 12.7 (0.8) % of gross profit 77.5 74.1 3.4 Operating margin (excluding restructuring charges) 3.4 4.4 (1.0)EMEA Commercial Revenue from services (including fee-based income) $ 238.9 $ 283.3 (15.7)% (22.8)% Fee-based income 4.3 7.5 (42.6) (45.6) Gross profit 37.4 47.6 (21.5) (28.3) SG&A expenses excluding restructuring charges 35.2 51.4 (31.4) Restructuring charges 4.9 3.0 60.0 Total SG&A expenses 40.1 54.4 (26.3) (32.5) Earnings from operations (2.7) (6.8) 59.9 Earnings from operations excluding restructuring charges 2.2 (3.8) NM Gross profit rate 15.7% 16.8% (1.1)pts. Expense rates (excluding restructuring charges): % of revenue 14.8 18.1 (3.3) % of gross profit 94.2 107.8 (13.6) Operating margin (excluding restructuring charges) 0.9 (1.3) 2.2 KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (continued) (UNAUDITED) (In millions of dollars) Fourth Quarter —————————————– Constant 2009 2008 Currency (14 Weeks)(13 Weeks) Change Change ——– ——– ——– ——-EMEA PT Revenue from services (including fee-based income) $ 39.6 $ 38.4 3.0 % (6.1)% Fee-based income 3.6 5.5 (34.4) (37.4) Gross profit 9.8 11.2 (12.7) (19.4) Total SG&A expenses 10.6 11.7 (9.5) (17.1) Earnings from operations (0.8) (0.5) (58.0) Gross profit rate 24.7% 29.1% (4.4)pts. Expense rates: % of revenue 26.8 30.5 (3.7) % of gross profit 108.5 104.7 3.8 Operating margin (2.1) (1.4) (0.7)APAC Commercial Revenue from services (including fee-based income) $ 83.0 $ 73.5 12.9 % (2.2)% Fee-based income 2.9 3.0 (6.2) (15.2) Gross profit 12.1 11.4 6.8 (7.8) SG&A expenses excluding restructuring charges 11.6 12.4 (7.2) Restructuring charges 1.4 – NM Total SG&A expenses 13.0 12.4 4.6 (9.8) Earnings from operations (0.9) (1.0) 19.7 Earnings from operations excluding restructuring charges 0.5 (1.0) NM Gross profit rate 14.6% 15.5% (0.9)pts. Expense rates (excluding restructuring charges): % of revenue 13.9 16.9 (3.0) % of gross profit 95.0 109.3 (14.3) Operating margin (excluding restructuring charges) 0.7 (1.4) 2.1APAC PT Revenue from services (including fee-based income) $ 7.2 $ 7.2 (0.4)% (15.9)% Fee-based income 1.0 0.8 29.9 17.7 Gross profit 2.1 1.9 7.8 (7.0) Total SG&A expenses 2.6 2.2 19.3 2.4 Earnings from operations (0.5) (0.3) (106.4) Gross profit rate 28.6% 26.4% 2.2 pts. Expense rates: % of revenue 35.8 29.9 5.9 % of gross profit 125.2 113.1 12.1 Operating margin (7.2) (3.5) (3.7) KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (continued) (UNAUDITED) (In millions of dollars) Fourth Quarter ——————————————- Constant 2009 2008 Currency (14 Weeks) (13 Weeks) Change Change ——— ——— ——- ——–OCG Revenue from services (including fee-based income) $ 68.2 $ 68.4 (0.3)% (1.3)% Fee-based income 6.0 7.2 (16.2) (19.6) Gross profit 15.5 18.9 (18.0) (19.6) SG&A expenses excluding restructuring charges 17.9 18.0 (0.8) Restructuring charges 1.3 0.4 239.5 Total SG&A expenses 19.2 18.4 4.1 1.1 Earnings from operations (3.7) 0.5 NM Earnings from operations excluding restructuring charges (2.4) 0.9 NM Gross profit rate 22.7% 27.6% (4.9)pts. Expense rates (excluding restructuring charges): % of revenue 26.2 26.4 (0.2) % of gross profit 115.7 95.6 20.1 Operating margin (excluding restructuring charges) (3.6) 1.2 (4.8)Corporate Expense SG&A expenses excluding restructuring charges $ 17.7 $ 20.6 (14.2)% Restructuring charges 1.5 0.3 418.1 Total SG&A expenses 19.2 20.9 (8.1) (8.1)Asset Impairments $ – $ 80.5 (100.0)%Consolidated Total (excluding intersegment activity) Revenue from services (including fee-based income) $ 1,194.1 $ 1,279.1 (6.6)% (10.0)% Fee-based income 21.5 30.5 (29.5) (33.0) Gross profit 188.3 224.6 (16.2) (19.4) SG&A expenses excluding restructuring charges 187.9 223.5 (16.0) Restructuring charges 13.4 4.3 209.0 Total SG&A expenses 201.3 227.8 (11.7) (15.1) Earnings from operations (13.0) (83.7) 84.5 Earnings from operations excluding restructuring charges 0.4 (79.4) NM Gross profit rate 15.8% 17.6% (1.8)pts. Expense rates (excluding restructuring charges): % of revenue 15.7 17.5 (1.8) % of gross profit 99.8 99.4 0.4 Operating margin (excluding restructuring charges) 0.0 (6.2) 6.2 KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (UNAUDITED) (In millions of dollars) December Year to Date ——————————————– Constant 2009 2008 Currency (53 Weeks) (52 Weeks) Change Change ——— ——— ——— ——–Americas Commercial Revenue from services (including fee-based income) $ 1,980.3 $ 2,516.7 (21.3) % (20.3)% Fee-based income 6.6 15.7 (58.4) (56.8) Gross profit 290.7 399.0 (27.1) (26.3) SG&A expenses excluding restructuring charges 273.2 328.2 (16.7) Restructuring charges 7.2 0.9 NM Total SG&A expenses 280.4 329.1 (14.8) (13.8) Earnings from operations 10.3 69.9 (85.1) Earnings from operations excluding restructuring charges 17.5 70.8 (75.2) Gross profit rate 14.7% 15.9% (1.2)pts. Expense rates (excluding restructuring charges): % of revenue 13.8 13.0 0.8 % of gross profit 93.9 82.2 11.7 Operating margin (excluding restructuring charges) 0.9 2.8 (1.9)Americas PT Revenue from services (including fee-based income) $ 792.6 $ 938.2 (15.5)% (15.4)% Fee-based income 9.4 19.4 (51.5) (51.4) Gross profit 125.1 161.7 (22.6) (22.5) SG&A expenses excluding restructuring charges 100.9 113.3 (10.9) Restructuring charges 1.0 – NM Total SG&A expenses 101.9 113.3 (10.0) (9.8) Earnings from operations 23.2 48.4 (52.2) Earnings from operations excluding restructuring charges 24.2 48.4 (50.0) Gross profit rate 15.8% 17.2% (1.4)pts. Expense rates (excluding restructuring charges): % of revenue 12.7 12.1 0.6 % of gross profit 80.7 70.1 10.6 Operating margin (excluding restructuring charges) 3.0 5.2 (2.2)EMEA Commercial Revenue from services (including fee-based income) $ 895.2 $ 1,310.5 (31.7)% (24.9)% Fee-based income 16.6 39.5 (58.0) (52.6) Gross profit 140.2 227.3 (38.4) (32.5) SG&A expenses excluding restructuring charges 150.3 226.5 (33.7) Restructuring charges 15.6 3.9 301.4 Total SG&A expenses 165.9 230.4 (28.0) (20.2) Earnings from operations (25.7) (3.1) NM Earnings from operations excluding restructuring charges (10.1) 0.8 NM Gross profit rate 15.7% 17.4% (1.7)pts. Expense rates (excluding restructuring charges): % of revenue 16.8 17.3 (0.5) % of gross profit 107.2 99.6 7.6 Operating margin (excluding restructuring charges) (1.1) 0.1 (1.2) KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (continued) (UNAUDITED) (In millions of dollars) December Year to Date —————————————- Constant 2009 2008 Currency (53 Weeks)(52 Weeks) Change Change ——– ——– ——– ——-EMEA PT Revenue from services (including fee-based income) $ 141.9 $ 172.5 (17.8)% (10.7)% Fee-based income 15.7 26.8 (41.2) (33.2) Gross profit 37.8 51.2 (26.2) (18.8) Total SG&A expenses 40.6 48.9 (16.9) (8.5) Earnings from operations (2.8) 2.3 NM Gross profit rate 26.6% 29.7% (3.1)pts. Expense rates: % of revenue 28.6 28.3 0.3 % of gross profit 107.6 95.5 12.1 Operating margin (2.0) 1.3 (3.3)APAC Commercial Revenue from services (including fee-based income) $ 284.9 $ 336.0 (15.2)% (11.0)% Fee-based income 9.7 17.0 (43.0) (40.6) Gross profit 41.6 56.3 (26.1) (22.6) SG&A expenses excluding restructuring charges 44.6 56.6 (21.3) Restructuring charges 1.6 – NM Total SG&A expenses 46.2 56.6 (18.5) (14.8) Earnings from operations (4.6) (0.3) NM Earnings from operations excluding restructuring charges (3.0) (0.3) NM Gross profit rate 14.6% 16.8% (2.2)pts. Expense rates (excluding restructuring charges): % of revenue 15.6 16.8 (1.2) % of gross profit 107.0 100.5 6.5 Operating margin (excluding restructuring charges) (1.0) (0.1) (0.9)APAC PT Revenue from services (including fee-based income) $ 25.4 $ 34.3 (26.0)% (24.3)% Fee-based income 3.8 5.1 (25.0) (21.0) Gross profit 7.7 10.2 (25.1) (22.6) Total SG&A expenses 9.2 10.7 (14.2) (9.9) Earnings from operations (1.5) (0.5) (224.9) Gross profit rate 30.2% 29.8% 0.4 pts. Expense rates: % of revenue 36.2 31.2 5.0 % of gross profit 119.8 104.6 15.2 Operating margin (6.0) (1.4) (4.6) KELLY SERVICES, INC. AND SUBSIDIARIES RESULTS OF OPERATIONS BY SEGMENT (continued) (UNAUDITED) (In millions of dollars) December Year to Date —————————————— Constant 2009 2008 Currency (53 Weeks) (52 Weeks) Change Change ——— ——— ——– ——–OCG Revenue from services (including fee-based income) $ 219.9 $ 233.3 (5.7)% (4.7)% Fee-based income 24.4 27.8 (12.3) (9.4) Gross profit 59.7 72.9 (18.0) (16.1) SG&A expenses excluding restructuring charges 69.6 69.5 0.0 Restructuring charges 1.9 0.5 328.4 Total SG&A expenses 71.5 70.0 2.0 4.3 Earnings from operations (11.8) 2.9 NM Earnings from operations excluding restructuring charges (9.9) 3.4 NM Gross profit rate 27.2% 31.2% (4.0)pts. Expense rates (excluding restructuring charges): % of revenue 31.7 29.8 1.9 % of gross profit 116.6 95.6 21.0 Operating margin (excluding restructuring charges) (4.5) 1.4 (5.9)Corporate Expense SG&A expenses excluding restructuring charges $ 77.5 $ 108.2 (28.4)% Restructuring charges 2.6 1.2 116.3 Total SG&A expenses 80.1 109.4 (26.8) (26.8)Asset Impairments $ 53.1 $ 80.5 (34.1)%Consolidated Total (excluding intersegment activity) Revenue from services (including fee-based income) $ 4,314.8 $ 5,517.3 (21.8)% (19.2)% Fee-based income 86.1 151.3 (43.1) (39.2) Gross profit 701.7 977.6 (28.2) (25.7) SG&A expenses excluding restructuring charges 764.8 960.9 (20.4) Restructuring charges 29.9 6.5 360.9 Total SG&A expenses 794.7 967.4 (17.9) (14.8) Earnings from operations (146.1) (70.3) (107.8) Earnings from operations excluding restructuring charges (116.2) (63.8) (82.0) Gross profit rate 16.3% 17.7% (1.4)pts. Expense rates (excluding restructuring charges): % of revenue 17.7 17.4 0.3 % of gross profit 109.0 98.3 10.7 Operating margin (excluding restructuring charges) (2.7) (1.2) (1.5) KELLY SERVICES, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In millions of dollars) January 3, December 28, 2010 2008 ———— ————Current Assets Cash and equivalents $ 88.9 $ 118.3 Trade accounts receivable, less allowances of $15.0 and $17.0, respectively 717.9 815.8 Prepaid expenses and other current assets 70.6 62.0 Deferred taxes 21.0 31.9 ———— ———— Total current assets 898.4 1,028.0Property and Equipment, Net 127.1 151.3Noncurrent Deferred Taxes 77.5 40.0Goodwill, Net 67.3 117.8Other Assets 131.4 120.2 ———— ————Total Assets $ 1,301.7 $ 1,457.3 ============ ============Current Liabilities Short-term borrowings and current portion of long-term debt $ 79.6 $ 35.2 Accounts payable and accrued liabilities 182.6 244.1 Accrued payroll and related taxes 208.3 243.2 Accrued insurance 19.7 26.3 Income and other taxes 47.4 51.8 ———— ———— Total current liabilities 537.6 600.6Noncurrent Liabilities Long-term debt 57.5 80.0 Accrued insurance 47.3 46.9 Accrued retirement benefits 76.9 61.6 Other long-term liabilities 16.0 15.3 ———— ———— Total noncurrent liabilities 197.7 203.8Stockholders’ Equity Common stock 40.1 40.1 Treasury stock (107.2) (111.2) Paid-in capital 36.9 35.8 Earnings invested in the business 571.5 676.0 Accumulated other comprehensive income 25.1 12.2 ———— ———— Total stockholders’ equity 566.4 652.9 ———— ————Total Liabilities and Stockholders’ Equity $ 1,301.7 $ 1,457.3 ============ ============ ———— ————STATISTICS: Working Capital $ 360.8 $ 427.4 Current Ratio 1.7 1.7 Debt-to-capital % 19.5% 15.0% Global Days Sales Outstanding 51 50 KELLY SERVICES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWSFOR THE 53 WEEKS ENDED JANUARY 3, 2010 AND 52 WEEKS ENDED DECEMBER 28, 2008 (In millions of dollars) 2009 2008 ——— ———Cash flows from operating activities Net loss $ (104.5) $ (82.2) Noncash adjustments: Impairment of assets 53.1 80.5 Depreciation and amortization 40.9 46.0 Provision for bad debts 2.2 6.7 Stock-based compensation 5.1 4.4 Other, net (2.2) 3.7 Changes in operating assets and liabilities (11.8) 42.5 ——— ——— Net cash from operating activities (17.2) 101.6 ——— ———Cash flows from investing activities Capital expenditures (13.1) (31.1) Acquisition of companies, net of cash received (7.5) (32.7) Other investing activities (2.8) (0.2) ——— ——— Net cash from investing activities (23.4) (64.0) ——— ———Cash flows from financing activities Net change in revolving line of credit 52.7 (34.2) Repayment of debt (30.5) – Proceeds from debt – 42.5 Dividend payments – (19.1) Purchase of treasury stock – (8.0) Other financing activities (12.8) 10.0 ——— ——— Net cash from financing activities 9.4 (8.8) ——— ———Effect of exchange rates on cash and equivalents 1.8 (3.3) ——— ———Net change in cash and equivalents (29.4) 25.5Cash and equivalents at beginning of period 118.3 92.8 ——— ———Cash and equivalents at end of period $ 88.9 $ 118.3 ========= ========= KELLY SERVICES, INC. AND SUBSIDIARIES REVENUE FROM SERVICES (UNAUDITED) (In millions of dollars) Fourth Quarter (Commercial, PT and OCG) ——————————————— % Change 2009 2008 Constant (14 Weeks) (13 Weeks) US$ Currency ———– ———– ——— ———Americas United States $ 733.1 $ 781.5 (6.2)% (6.2)% Canada 51.5 50.2 2.7 (9.9) Mexico 19.0 18.1 5.3 6.6 Puerto Rico 15.0 18.7 (19.7) (19.7) ———– ———–Total Americas 818.6 868.5 (5.7) (6.4)EMEA France 78.7 75.1 4.7 (6.2) United Kingdom 43.1 80.7 (46.5) (48.1) Switzerland 38.8 41.4 (6.4) (17.5) Russia 19.9 22.3 (10.8) (3.3) Portugal 19.4 15.6 24.4 11.3 Italy 19.0 25.2 (24.8) (32.9) Germany 17.6 17.7 0.3 (10.5) Norway 17.3 16.9 1.7 (14.2) Other 29.0 32.7 (11.4) (20.1) ———– ———–Total EMEA 282.8 327.6 (13.7) (21.0)APAC Australia 30.4 26.0 16.9 (13.1) Singapore 17.9 16.1 10.9 4.1 Malaysia 13.7 12.3 12.3 7.7 Other 30.7 28.6 7.0 (3.8) ———– ———–Total APAC 92.7 83.0 11.6 (3.5)Total Kelly Services, Inc. $ 1,194.1 $ 1,279.1 (6.6)% (10.0)% =========== =========== KELLY SERVICES, INC. AND SUBSIDIARIES REVENUE FROM SERVICES (UNAUDITED) (In millions of dollars) December Year to Date (Commercial, PT and OCG) ———————————————- % Change 2009 2008 Constant (53 Weeks) (52 Weeks) US$ Currency ———– ———– ——— ———Americas United States $ 2,634.3 $ 3,237.1 (18.6)% (18.6)% Canada 183.4 237.8 (22.9) (17.5) Mexico 66.5 76.2 (12.7) 6.2 Puerto Rico 57.9 77.4 (25.2) (25.2) ———– ———–Total Americas 2,942.1 3,628.5 (18.9) (18.2)EMEA France 272.7 350.8 (22.3) (18.3) United Kingdom 206.7 398.0 (48.1) (37.0) Switzerland 138.6 184.9 (25.1) (25.2) Italy 72.9 131.9 (44.7) (41.5) Russia 65.4 90.9 (28.0) (8.9) Germany 65.1 83.0 (21.5) (17.2) Norway 61.7 86.1 (28.4) (18.9) Portugal 59.5 27.5 116.5 124.9 Other 111.2 154.4 (28.0) (22.1) ———– ———–Total EMEA 1,053.8 1,507.5 (30.1) (23.3)APAC Australia 98.3 133.7 (26.4) (21.3) Singapore 64.4 71.3 (9.6) (7.3) Malaysia 50.1 55.2 (9.2) (4.1) Other 106.1 121.1 (12.5) (9.0) ———– ———–Total APAC 318.9 381.3 (16.4) (12.3)Total Kelly Services, Inc. $ 4,314.8 $ 5,517.3 (21.8)% (19.2)% =========== =========== KELLY SERVICES, INC. AND SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (In millions of dollars except per share data) December Fourth Quarter Year to Date —————— —————— 2009 2008 2009 2008 ——– ——– ——– ——–Pretax loss from operations $ (13.0) $ (83.7) $ (146.1) $ (70.3)Restructuring charges (Note 1) 13.4 4.3 29.9 6.5Asset impairments (Note 2) – 80.5 53.1 80.5Litigation charges – – 5.3 22.5 ——– ——– ——– ——–Earnings (loss) from operations excluding restructuring, asset impairment and litigation charges $ 0.4 $ 1.1 $ (57.8) $ 39.2 ======== ======== ======== ======== Fourth Quarter ————————————– 2009 2008 —————— —————— Per Per Amount Share Amount Share ——– ——– ——– ——–Loss from continuing operations, net of tax $ (8.2) $ (0.23) $ (88.6) $ (2.55)Restructuring charges, net of taxes (Note 1) 10.1 0.29 3.7 0.11Asset impairments, net of taxes (Note 2) – – 77.2 2.22 ——– ——–Earnings (loss) from continuing operations excluding restructuring and asset impairment charges, net of taxes $ 1.9 $ 0.05 $ (7.7) $ (0.22) ======== ======== ======== ======== December Year to Date ————————————– 2009 2008 —————— —————— Per Per Amount Share Amount Share ——– ——– ——– ——–Loss from continuing operations, net of tax $ (105.1) $ (3.01) $ (81.7) $ (2.35)Restructuring charges, net of taxes (Note 1) 24.0 0.69 5.3 0.15Asset impairments, net of taxes (Note 2) 50.0 1.43 77.2 2.22Litigation charges, net of taxes 3.3 0.09 13.9 0.40 ——– ——–(Loss) earnings from continuing operations excluding restructuring, asset impairment and litigation charges, net of taxes $ (27.8) $ (0.80) $ 14.7 $ 0.42 ======== ======== ======== ======== KELLY SERVICES, INC. AND SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED)Management believes that the non-GAAP (Generally Accepted AccountingPrinciples) information excluding the impairment, restructuring andlitigation charges is useful to understand the Company’s fiscal 2009financial performance and increases comparability. Specifically,Management believes that excluding these items allows for a more meaningfulcomparison of current period operating performance with the operatingresults of prior periods. These non-GAAP measures may have limitations asanalytical tools because they exclude items which can have a materialimpact on cash flow and earnings per share. As a result, Managementconsiders these measures, along with reported results, when it reviews andevaluates the Company’s financial performance. Management believes thatthese measures provide greater transparency to investors and provideinsight into how Management is evaluating the Company’s financialperformance. Non-GAAP measures should not be considered a substitute for,or superior to, measures of financial performance prepared in accordancewith GAAP.(1) Restructuring charges represent global costs incurred in connection with the reduction in the number of permanent employees and the consolidation, sale or closure of branch locations. These costs include severance, lease terminations, asset write-offs and other miscellaneous costs.(2) For 2009, asset impairment charges include adjustments to the value of goodwill for the Company’s Americas Commercial, EMEA PT and APAC Commercial reporting segments, and long-lived assets and intangible assets related to Japan and Europe. For 2008, asset impairment charges include adjustments to the value of goodwill for the Company’s EMEA Commercial segment, the Company’s investment in Tempstaff, and assets related to operations in the U.K.

Friday, February 5th, 2010 Uncategorized Comments Off on Kelly Services (KELYA) Reports 4th Quarter 2009 and Year-End Results

SkyPeople Fruit Juice, Inc. (SPU) Receives Independent Research Coverage from EquityNet Research

EquityNet Research, an independent West Coast equity research firm, announced today that it has initiated coverage of SkyPeople Fruit Juice, Inc. (AMEX: SPU). Investors may receive a full copy of the report and disclosure requirements at EquityNet Research’s Website: www.equitynet.net.

SkyPeople, through its subsidiary Shaanxi Tianren Organic Food Co., Ltd., focuses on producing and selling special concentrated fruit juices, fast-frozen and freeze-dried fruits and vegetables, and fruit juice drink in the People’s Republic of China. The company’s distribution network, already one of the largest in China, is constantly expanding and now includes the United States, Japan, the European Union, the Middle East, Russia, Israel and South Korea.

Randy Lewis, CFA, Founder and Senior Analyst with EquityNet who is covering the Company, stated, “Certainly from a fundamental standpoint, SkyPeople is exhibiting phenomenal growth and financial strength in the midst of a global economic downturn. We feel this is a testament to the increasing industry demand and business model that SkyPeople is executing, and certainly solidifies our confidence in the Company moving forward.”

He continued, “We believe that the Company holds several competitive advantages, including superior technology, advantageous geography and a diversified product line. In addition, the move into branded juices, as a complement to its traditional concentrate lines, was a very smart move. And the push marketing strategy employed with its juice distributors seems to be paying off handsomely.”

Friday, February 5th, 2010 Uncategorized Comments Off on SkyPeople Fruit Juice, Inc. (SPU) Receives Independent Research Coverage from EquityNet Research

Overhill Farms (OFI) Reports Net Income of 19 Cents per Share on Revenues of $56.2 Million

LOS ANGELES, CA — (Marketwire) — 02/04/10 — Overhill Farms, Inc. (NYSE Amex: OFI) today reported net income of $3.1 million, or $0.19 per basic and diluted common share, on net revenues of $56.2 million for the first quarter of fiscal 2010, which ended December 27, 2009. This is an increase of 20.5% from the earnings of $2.5 million or $0.16 per basic and diluted share for the first quarter of fiscal 2009, on an increase in revenues of 1.7% from the $55.3 million of the first quarter of fiscal 2009.

James Rudis, the Company’s Chairman, President and Chief Executive Officer, said, “We are pleased to be able to report these strong results despite the continuing challenges of a difficult economic environment for our customers and our company. Thanks to improvements in our gross margin, we produced a year-over-year increase of more than 20% in net income. Compared to the immediately prior quarter, our net income increased 118% on a 16% increase in revenues.”

Mr. Rudis added, “Based on our strong results, we were able to make a voluntary debt prepayment of $5 million during the period, ending the quarter with cash of $4.9 million. Assuming continued strong performance, our goal is to substantially pay down our remaining debt by the end of the calendar year, which would enable us to consider a number of alternatives for further enhancing stockholder value.”

Mr. Rudis noted that sales to foodservice customers more than doubled from the year-earlier level, supporting the Company’s belief that the foodservice sector continues to represent a significant opportunity. He said this positive outlook is supported by the initial response from major foodservice companies to the Company’s alliance with J.R. Simplot Company formed during the fourth quarter of fiscal 2009, which has already resulted in interest from potential new customers.

Approximately $1.5 million of net revenues in the first quarter of fiscal 2010 were attributable to January 2010 orders that customers placed early because the Company’s facilities were closed over the Christmas and New Year holidays, which were in the first week of the second fiscal quarter.

Retail net revenues were $35.1 million for the first quarter of fiscal 2010, a decrease of $7.3 million or 17.3% from the $42.5 million of the first quarter of the prior fiscal year. The decrease was primarily due to reduced volume from H. J. Heinz Company, as previously announced. The Company anticipates that sales to other retail customers and foodservice accounts will continue to offset reductions in sales to Heinz during fiscal and calendar 2010.

Foodservice net revenues increased by $9.7 million, or 102.1%, to $19.2 million for the first quarter of fiscal 2010, from $9.5 million for the year-earlier quarter. The increase in foodservice revenues was due to higher volume from existing customers, as well as new products for existing and new accounts.

Airline net revenues decreased by $1.4 million, or 42.4%, to $1.9 million for the first quarter of fiscal 2010, from $3.3 million for the first quarter of the prior fiscal year. This decline reflects continuing efforts by the airline industry to cut costs, which may cause further decreases in future periods. The airline category represented 3.4% of total net revenues for the first quarter of fiscal 2010, compared to 6% for the first quarter of the prior fiscal year. The Company continues to transition to opportunities outside of the airline category.

Gross profit as a percentage of net revenues increased to 14.0% for the first quarter of fiscal 2010, from 13.6% for the first quarter of fiscal 2009. Gross profit for the first quarter of fiscal 2010 increased by $379,000, or 5.1% to $7.9 million, from $7.5 million for the first quarter of fiscal 2009. This increase was attributed to improved operating efficiencies and yields, and favorable pricing in commodity contracts, offset partially by price reductions to certain customers.

The Company also announced that it has received favorable rulings, detailed below, in previously disclosed employment-related legal actions. These actions arose out of the termination on May 31, 2009, of approximately 260 employees, following notification by the Internal Revenue Service that these employees were using invalid social security numbers.

On April 28, 2009, Local 770 of the United Food and Commercial Workers Union sought arbitration regarding the then-pending termination of these workers. On January 11, 2010, the arbitrator dismissed the Union’s grievance. On January 29, 2010, the Union filed a petition to vacate the decision in the binding arbitration. The Company believes that the Union has no legitimate basis to vacate the arbitrator’s decision, and intends to seek dismissal of the Union’s petition and to pursue other appropriate remedies.

On June 20, 2009, the Company filed a lawsuit against Nativo Lopez and six other leaders of what the Company believes is an illegal campaign to force it to rehire the workers terminated because of their use of invalid social security numbers. The defendants attempted unsuccessfully to have the Company’s action dismissed. On November 13, 2009, the court ruled that the Company had established a probability of prevailing on the merits, and had submitted substantial evidence that the defendants’ accusations of racism were false, harmed the Company, and were made with malice. The Company will continue to pursue its action against the defendants.

“We are pleased that a number of issues related to the terminations are nearing resolution,” Mr. Rudis said. “These matters have required use of Company resources and management time, but our actions were necessary to protect the Company’s interests.”

About Overhill Farms

Overhill Farms is a leading value-added supplier of custom high quality prepared frozen foods for branded retail, private label, foodservice and airline customers. Its product line includes entrées, plated meals, bulk-packed meal components, pastas, soups, sauces, poultry, meat and fish specialties, as well as organic and vegetarian offerings. The Company’s capabilities give its customers a one-stop solution for new product development, precise replication of existing recipes, product manufacturing and packaging. Its customers include prominent nationally recognized names such as Jenny Craig, Inc., Safeway Inc., Panda Restaurant Group, Inc., H. J. Heinz Company, Pinnacle Foods Group LLC and American Airlines, Inc.

This news release contains disclosures that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs and include, but are not limited to, statements about the company’s operations and financial performance and condition and statements regarding expectations of continued or increased sales volumes and revenues, margins, profitability, production efficiencies and expansions, cash flows and growth, anticipated amounts and timing of growth in the company’s customer base and business in the foodservice and retail market sectors, ability and desire to make further voluntary debt reductions, ability to successfully resolve outstanding legal matters. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, or which include words such as “continue,” “efforts,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “projects,” “forecasts,” “strategy,” “will,” “goal,” “objective,” “target,” “prospects,” “optimistic,” “confident,” “likely,” “probable” or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), on-going business strategies or prospects, and possible future company actions, which may be provided by management, are also forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the impact of competitive products and pricing; fulfillment by suppliers of existing raw material contracts; market conditions that may affect the costs and/or availability of raw materials and the Company’s ability to obtain favorable long-term purchase commitments for raw materials, and of fuels, energy, logistics and labor as well as the market for the company’s products, including customers’ ability to pay and consumer demand; changes in business environment, including actions of competitors and changes in customer preferences, as well as disruptions to customers’ businesses; seasonality in the retail category; loss of key customers due to competitive environment or production being moved in-house by customers; difficulties that may be encountered in attracting and retaining new customers; natural disasters that can impact, among other things, costs of fuel and raw materials; the occurrence of acts of terrorism, or acts of war; changes in governmental laws and regulations; change in control due to takeover or other significant changes in ownership; financial viability and resulting effect on revenues and collectability of accounts receivable of customers during recessionary periods; ability to obtain additional financing as and when needed, and rising costs of credit that may be associated with new borrowings; voluntary or government-mandated food recalls; and other factors as may be discussed in the company’s Annual Report on Form 10-K for the year ended September 27, 2009, and other reports filed with the Securities and Exchange Commission.

                         OVERHILL FARMS, INC.

                   CONDENSED SUMMARY OF OPERATIONS

                                                  For the Quarter Ended
                                                --------------------------
                                                December 27,  December 28,
                                                    2009          2008
                                                ------------  ------------

Net revenues                                    $ 56,232,538  $ 55,272,029
Cost of sales                                     48,346,408    47,764,510
                                                ------------  ------------
Gross profit                                       7,886,130     7,507,519

Selling, general and administrative expenses       2,561,781     2,534,216
                                                ------------  ------------

Operating income                                   5,324,349     4,973,303

Interest expense:
  Interest expense                                  (331,114)     (712,584)
  Amortization of debt discount and deferred
   financing costs                                  (101,504)     (101,504)
                                                ------------  ------------
Total interest expense                              (432,618)     (814,088)

Other expense                                         (1,000)            -
                                                ------------  ------------

Income before income taxes                         4,890,731     4,159,215

Income taxes                                       1,837,936     1,626,252

Net income                                      $  3,052,795  $  2,532,963
                                                ============  ============

Net income per share:
  Basic                                         $       0.19  $       0.16
                                                ============  ============
  Diluted                                       $       0.19  $       0.16
                                                ============  ============

Shares used in computing net income per share:
  Basic                                           15,823,271    15,823,271
  Diluted                                         16,051,619    16,018,339
Thursday, February 4th, 2010 Uncategorized Comments Off on Overhill Farms (OFI) Reports Net Income of 19 Cents per Share on Revenues of $56.2 Million

Romi Offers to Acquire Hardinge (HDNG) for $8 Per Share in Cash

Feb. 4, 2010 (PR Newswire) — Romi Offers to Acquire Hardinge for $8 Per Share in Cash

SANTA BARBARA D’OESTE, Brazil — Industrias Romi S.A. (Bovespa: ROMI3) (“Romi”), a leading global manufacturer of machine tools, today announced that it has submitted an all-cash offer to the Board of Directors of Hardinge Inc. (Nasdaq: HDNG) (“Hardinge”) to acquire all of the outstanding shares of Hardinge for $8.00 per share.  The offer represents a premium of 46% to Hardinge’s closing share price on February 3, 2010, the last trading day prior to the public disclosure of Romi’s offer, a premium of over 63% to Hardinge’s closing share price on December 14, 2009, when Romi first formally communicated its interest to Hardinge in pursuing a business combination, and a premium of over 48% to Hardinge’s 90-day weighted average share price through Wednesday, February 3, 2010.  The offer is not subject to any financing condition and will be funded entirely from Romi’s internal resources.

“We have great respect for Hardinge and together we can create a strong, diversified global platform for the machine tools business with considerable opportunities for further growth and innovation,” said Livaldo Aguiar dos Santos, Chief Executive Officer of Romi.

“Our all-cash offer provides immediate liquidity at a superior value to Hardinge’s future prospects as a stand-alone company.  In addition to delivering a significant premium to Hardinge shareholders, Romi believes the combination is in the best interests of Hardinge’s employees, customers and partners.  The combined company will have the size and scale to invest in strategic opportunities to thrive in an increasingly challenging and competitive industry environment and to expand in emerging markets,” said Mr. dos Santos.

“We are committed to maintaining a strong presence in Hardinge’s hometown of Elmira, New York, as well as in the other communities where Hardinge operates, and we believe that the skilled employees of Hardinge will have great prospects as part of the Romi team,” continued Mr. dos Santos.  “We hope that Hardinge’s Board and management will recognize this opportunity, as well as the potential benefits for all Hardinge stakeholders.  We are confident that by working together with Hardinge management, we will be able to successfully integrate our operations to realize our joint potential.”

To date, Hardinge has refused to enter into any meaningful dialogue to explore the merits and potential terms of a transaction.  Romi has made numerous efforts to engage Hardinge management in negotiations with respect to the proposed transaction for more than two months, including the delivery of a draft confidentiality agreement to Hardinge on November 25, 2009, and a formal communication to Hardinge of Romi’s intentions to pursue a business combination on December 14, 2009.

Most recently, Romi sent a letter to Hardinge on December 30, 2009 in which Romi submitted an offer to acquire Hardinge at a price per share of up to $8.00.  On January 26, 2010, without making any effort to discuss the details of Romi’s proposal, Hardinge sent a letter rejecting the offer.

“We look forward to Hardinge’s careful consideration of what we believe is a very attractive offer and an open dialogue with Hardinge’s Board of Directors to complete this transaction,” concluded Mr. dos Santos.

Following is the text of a letter Romi today sent to Hardinge’s Board of Directors, with the goal of moving towards negotiation of a transaction:

February 4, 2010
Board of Directors of Hardinge Inc.
One Hardinge Drive
Elmira, NY 14902-1507

Attention: Mr. Kyle H. Seymour, Chairman of the Board of Directors

Dear Sirs:

As you are aware, Romi communicated its initial interest in pursuing a potential transaction with Hardinge on November 19, 2009 and has, during the past two months, consistently and repeatedly continued to convey our interest in a combination with Hardinge.  We are disappointed that Hardinge has refused to engage in meaningful dialogue to explore the merits and potential terms of a transaction.  Nonetheless, we continue to believe that a transaction will create a compelling combination that makes excellent strategic sense.

We are writing to offer to acquire 100% of the outstanding common stock of Hardinge for cash consideration of $8.00 per share.  This price represents a premium of over 63% to Hardinge’s share price on December 14, 2009, when we first formally made our intentions known to Hardinge.  The transaction will be funded entirely from Romi’s internal resources and will not be subject to any financing condition.

As Hardinge has not provided due diligence information to Romi, despite our repeated requests to gain access to such materials, our offer is by necessity based solely on publicly available information.  We continue to encourage Hardinge to enable us to begin an accelerated due diligence process, and our offer is subject to the execution of a mutually acceptable definitive merger agreement containing customary closing conditions, including requisite shareholder and regulatory approvals and the absence of any material adverse change in Hardinge’s business.  Our team remains prepared to immediately begin the due diligence process and to simultaneously negotiate a merger agreement.  As you know, we sent a confidentiality agreement to Hardinge on November 25, 2009 in order to commence the due diligence process, but to date we have not received any indication of Hardinge’s willingness to sign that agreement.

As we have stated in our previous correspondence to Mr. Richard L. Simons, President and Chief Executive Officer of Hardinge, we believe that our offer presents Hardinge shareholders with the opportunity to monetize their investment at a very attractive premium to current trading prices.  We also believe that this transaction offers significant strategic benefits for both of our companies.  We are excited for the opportunity to create a stronger entity with a global enhanced operating platform.  Together our combined portfolio, geographic diversification and exposure to global emerging markets will create a leader in machine tool manufacturing with a strong and diversified global platform for the machine tools business, enhanced innovation potential and an opportunity to accelerate growth in key Asian, Latin American and other markets.

We are confident that our management, in conjunction with Hardinge, will successfully integrate our companies.  We see great opportunities for the employees of Hardinge to join our team and intend to maintain a strong presence in Elmira, New York.

We are committed to completing a transaction with Hardinge and our Board of Directors has unanimously approved the submission of this offer.  It remains our strong preference to work together towards a negotiated transaction, but if necessary we are prepared to take our offer directly to your shareholders.

We look forward to the Hardinge Board and senior management team’s careful consideration of what we believe is a very attractive offer.  We hope to promptly begin an open dialogue to complete this compelling transaction.

Sincerely,
/s/ Livaldo Aguiar dos Santos
Livaldo Aguiar dos Santos
Industrias Romi S.A.
cc: Richard L. Simons
Chief Executive Officer
Hardinge Inc.

Advisors

HSBC Securities (USA) Inc. is acting as financial advisor and Shearman & Sterling LLP is acting as legal advisor to Romi on the proposed transaction.

About Romi

Industrias Romi S.A. (Bovespa: ROMI3), founded in 1930, is a market leader in the Brazilian machinery and equipment industry.  The company is listed in the “Novo Mercado” category, which is reserved for companies with the highest degree of corporate governance on the Bovespa.  The company manufactures machine tools, plastic injection and blow molding machines and parts made of grey, nodular or vermicular cast iron, which are supplied rough or machined.  The company’s products and services are sold globally and used by a variety of industries, such as the automotive, general consumer goods and industrial and agricultural machinery and equipment industries.

Important Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell securities of Hardinge.  Subject to future developments, additional documents regarding a transaction with Hardinge may be filed with the Securities and Exchange Commission (the “Commission”) and, if and when available, would be accessible for free at the Commission’s website at http://www.sec.gov.  Investors and security holders are urged to read such disclosure documents, if and when they become available, because they will contain important information.

Romi is not currently engaged in a solicitation of proxies from the shareholders of Hardinge.  However, in connection with Romi’s offer to acquire Hardinge, certain directors and officers of Romi may participate in meetings or discussions with Hardinge shareholders.  Romi does not believe that any of these persons is a “participant” in the solicitation of proxies under SEC rules.  If in the future Romi does engage in a solicitation of proxies from the shareholders of Hardinge in connection with its offer to acquire Hardinge, Romi will include the identity of people who, under SEC rules, may be considered “participants” in the solicitation of proxies from Hardinge shareholders in applicable SEC filings when they become available.

Forward-Looking Statements

Any statements made in this press release that are not statements of historical fact, including statements about our beliefs and expectations, including the proposed acquisition of Hardinge, are forward-looking statements within the meaning of the U.S. federal securities laws and should be evaluated as such.  Forward-looking statements include statements that may relate to our plans, objectives, strategies, goals, future events, future revenues or performance, and other information that is not historical information.  These forward-looking statements may be identified by words such as “anticipate,” “expect,” “suggest,” “plan,” believe,” “intend,” “estimate,” “target,” “project,” “could,” “should,” “may,” “will,” “would,” “continue,” “forecast,” and other similar expressions.

Although we believe that these-looking statements and projections are based on reasonable assumptions at the time they are made, you should be aware that many factors could cause actual results or events to differ materially from those expressed in the forward-looking statements and projections.  Factors that may materially affect such forward-looking statements include: our ability to successfully complete any proposed transaction or realize the anticipated benefits of a transaction; delays in obtaining any approvals for the transaction, or an inability to obtain them on the terms proposed or on the anticipated schedule.  Forward-looking statements, like all statements in this press release, speak only as of the date of this press release (unless another date is indicated).  Unless required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Thursday, February 4th, 2010 Uncategorized Comments Off on Romi Offers to Acquire Hardinge (HDNG) for $8 Per Share in Cash

Kulicke & Soffa (KLIC) Reports Results for its First Fiscal Quarter 2010

Press Release Source: Kulicke & Soffa Industries, Inc. On Thursday February 4, 2010, 7:00 am EST

FORT WASHINGTON, Pa.–(BUSINESS WIRE)–Kulicke & Soffa Industries, Inc. (NASDAQ:KLICNews) (“K&S”) today announced results for its first fiscal quarter ended January 2, 2010. For its first quarter, the Company reported net revenue of $128.4 million and net income of $15.8 million, or $0.21 per diluted share. This press release contains both GAAP results and non-GAAP measures.

On a non-GAAP basis* for the first quarter of fiscal 2010, the Company reported net revenue of $128.4 million and net income of $21.2 million, or $0.29 per diluted share.

Quarterly GAAP Results
From Continuing

Operations

Q1 2010 **Change vs. Q1 2009 **Change vs. Q4 2009
Net Revenue $128.4 million 243% 16%
Gross Profit $56.4 million 305% 19%
Gross Margin 43.9% 667 basis points 119 basis points
Net Income $15.8 million 181% 174%
Net Margin 12.3% 6,469 basis points 711 basis points
EPS – Diluted $0.21 166% 163%
Quarterly Non-GAAP Measures*
From Continuing

Operations

Q1 2010 **Change vs. Q1 2009 **Change vs. Q4 2009
Net Revenue $128.4 million 243% 16%
Gross Profit $56.4 million 306% 19%
Gross Margin 43.9% 679 basis points 120 basis points
Net Income $21.2 million 197% 96%
Net Margin 16.5% 7,498 basis points 673 basis points
EPS – Diluted $0.29 179% 84%
*Non-GAAP measures exclude: equity-based compensation; severance; facilities contractual commitments; tax settlement expense; amortization of intangibles; gain on extinguishment of debt; non-cash interest expense; tax settlement benefit; and related tax effects on non-GAAP adjustments (see reconciliations of GAAP results to Non-GAAP measures in the following financial schedules).
** As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.

Commenting on the results, Scott Kulicke, Chairman and Chief Executive Officer, said, “Results for our December quarter reflect the continuing strong semiconductor industry recovery, as well as our own efforts to expand our revenue base. Besides ball bonder demand driven by semiconductor unit volume growth, our revenue includes demand from the LED market and from the industry’s transition to copper wire bonding. In addition, we are seeing accelerating demand for our heavy wire wedge bonders. We expect these trends to continue through the March quarter, resulting in March quarter revenue in the range of $140 to $150 million.”

Key Product Trends

  • Ball bonder unit volumes increased approximately 23% over the September quarter levels
    • Conversion to copper wire bonding continues to accelerate; total copper kit volumes increased 146% over the September quarter to approximately 1,550
    • Continued strong demand for ball bonders from the LED market
  • Heavy wire wedge bonder demand accelerated late in the quarter and is expected to be strong at least through the March quarter
  • First purchase order received for iStackPSTM die bonder in January 2010

Financial Highlights

  • Gross Margin improved 119 basis points to 43.9%
  • Return on Invested Capital of 35.4%
  • Total cash and cash equivalents of $175.2 million as of January 2, 2010
  • Net revenue for the March quarter of fiscal 2010 is expected to be $140 to $150 million

See Reconciliation of Return on Invested Capital table.

Earnings Conference Call Details

A conference call to discuss these results will be held today, February 4, 2010 beginning at 9:00 am (ET). To access the conference call, interested parties may call (877) 407-8037 or 201-689-8037, or log on to www.kns.com/investors/events for listen-only mode. A replay will be available approximately one hour after the completion of the call by calling toll-free (877) 660-6853 or internationally (201) 612-7415 and using the following replay access codes: 5521 (account number) and 342765 (replay ID number). A replay will also be available on the K&S website at www.kns.com/investors/events. The replay will be available via phone and website for a limited time.

Discussion of Non-GAAP Measures

This press release contains non-GAAP measures as a supplement to the consolidated financial results presented in accordance with GAAP. The Company believes certain non-GAAP measures provide investors with an additional, useful perspective on the Company’s performance as seen through the eyes of management. Management uses non-GAAP measures along with GAAP financial results for: analyzing the performance of the Company’s businesses; strategic and tactical decision making; and determining compensation. The Company does not consider non-GAAP measures to be a substitute for, or superior to, financial results presented in accordance with GAAP. All of the non-GAAP measures included herein are reconciled to the most directly comparable GAAP results in the following financial statements. These non-GAAP measures may be calculated differently from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on a comprehensive set of accounting rules or principles and some of the adjustments reflect the exclusion of items that are recurring and will be reflected in the Company’s GAAP financial results for the foreseeable future.

Exclusions from GAAP Results

The Company excludes the following from its GAAP results in presenting non-GAAP measures:

Equity-based compensation expenses. The Company recognizes the fair value of its equity-based compensation in expenses. Equity-based compensation consists of common stock, stock options and performance-based and time-based restricted stock granted under the Company’s equity compensation plans. Equity-based compensation is a non-cash expense that can vary significantly in amount from period to period.

Other. The exclusion of certain other non-GAAP amounts allows for improved comparisons of the Company’s results to both prior periods and other companies. The Company excludes the following other items from non-GAAP measures as these items are not reflective of the performance of the Company’s ongoing businesses:

  • Severance plan
  • Facilities contractual commitments
  • Tax settlement expense
  • Amortization of intangibles
  • Gain on extinguishment of debt
  • Non-cash interest expense
  • Tax settlement benefit

Tax Adjustment. Non-GAAP measures are tax adjusted using the GAAP tax rate associated with each quarterly period. The tax rate is calculated by dividing each quarter’s GAAP tax expense, adjusted for discrete quarterly items, by the GAAP operating income for that quarter. Non-GAAP year-to-date measures are calculated by summing the associated quarterly non-GAAP measures, without further tax adjustments.

Non-GAAP Measures

The specific non-GAAP measures included herein are gross profit, gross margin, net income (loss), net margin, and earnings per share (“EPS”). The Company calculates these measures as follows:

Gross Profit. K&S non-GAAP gross profit excludes the effects of equity-based compensation expense recorded within cost of sales.

Gross Margin. K&S non-GAAP gross margin excludes the impact of equity-based compensation expense recorded within cost of sales.

Net Income (Loss) and EPS. K&S non-GAAP net income (loss) and EPS exclude equity-based compensation; severance; facilities contractual commitments; tax settlement expense; amortization of intangibles; gain on extinguishment of debt; non-cash interest expense; tax settlement benefit; and related tax effects on non-GAAP adjustments.

Net Margin. K&S non-GAAP net margin reflects the Company’s net margin excluding equity-based compensation; severance; facilities contractual commitments; tax settlement expense; amortization of intangibles; gain on extinguishment of debt; non-cash interest expense; tax settlement benefit; and related tax effects on non-GAAP adjustments.

About Kulicke & Soffa

Kulicke & Soffa (NASDAQ: KLICNews) is a global leader in the design and manufacture of semiconductor assembly equipment. As one of the pioneers of the industry, K&S has provided customers with market leading packaging solutions for decades. In recent years K&S has expanded its product offerings through strategic acquisitions, adding die bonding, wedge bonding and a broader range of expendable tools to its core ball bonding products. Combined with its extensive expertise in process technology, K&S is well positioned to help customers meet the challenges of assembling the next-generation semiconductor devices. (www.kns.com)

Caution Concerning Forward Looking Statements

In addition to historical statements, this press release contains statements relating to future events and our future results. These statements are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, and include, but are not limited to, statements that relate to increasing demand for ball bonders, the continuing semiconductor industry recovery, increasing demand for ball bonder products from the conversion to copper wire bonding and penetration of the LED market, continuing, accelerating demand for heavy wire wedge bonding products, future revenue, sales, demand for our products and product development. While these forward-looking statements represent our judgments and future expectations concerning our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to: difficult global economic conditions, which could result in, among other things, sharply lower demand for products containing semiconductors and for the Company’s products, and disruption of capital and credit markets; the risk of failure to successfully manage our operations; the risk of failure to successfully integrate Orthodyne; the risk that anticipated customer orders may not materialize or that orders received may be postponed or canceled, generally without charges; the volatility in the demand for semiconductors and our products and services; the risk that we may not be able to develop and manufacture new products and product enhancements on a timely and cost effective basis; acts of terrorism and violence; risks, such as changes in trade regulations, currency fluctuations, political instability and war, associated with a substantial foreign customer and supplier base and substantial foreign manufacturing operations; and the factors listed or discussed in Kulicke and Soffa Industries, Inc. 2009 Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission. Kulicke & Soffa Industries is under no obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

KULICKE & SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share and employee data)
(Unaudited)
Three months ended
December 27, January 2,
2008 * 2010
Net revenue $ 37,416 $ 128,415
Cost of sales 23,488 72,042
Gross profit 13,928 56,373
Selling, general and administrative 29,852 25,226
Research and development 15,400 13,161
Total operating expenses 45,252 38,387
Income (loss) from operations (31,324 ) 17,986
Interest income 754 97
Interest expense (2,079 ) (2,083 )
Gain on extinguishment of debt 1,179
Income (loss) from continuing operations, before tax (31,470 ) 16,000
Provision (benefit) for income taxes (11,882 ) 160
Income (loss) from continuing operations (19,588 ) 15,840
Income from discontinued operations, net of tax 22,727
Net income $ 3,139 $ 15,840
Income (loss) per share from continuing operations:
Basic $ (0.32 ) $ 0.23
Diluted $ (0.32 ) $ 0.21
Income per share from discontinued operations:
Basic $ 0.37 $
Diluted $ 0.37 $
Net income per share:
Basic $ 0.05 $ 0.23
Diluted $ 0.05 $ 0.21
Weighted average shares outstanding:
Basic 60,451 69,684
Diluted 60,451 73,687
Equity-based compensation expense included in continuing operations:
Cost of sales $ (29 ) $ 46
Selling, general and administrative (667 ) 714
Research and development 24 344
Total $ (672 ) $ 1,104
Three months ended
December 27, January 2,
Additional financial data: 2008 * 2010
Depreciation and amortization
Continuing operations $ 5,559 $ 4,513
Capital expenditures
Continuing operations $ 2,433 $ 1,096
December 27, January 2,
2008 * 2010
Backlog of orders
Continuing operations $ 53,000 $ 36,000
Number of employees
Continuing operations 2,434 2,574
* As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.
KULICKE & SOFFA INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
October 3, January 2,
2009 * 2010
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 144,560 $ 175,207
Restricted cash 281 216
Accounts and notes receivable, net of allowance for doubtful accounts of $1,378 and $1,009 respectively 95,779 84,370
Inventories, net 41,489 49,784
Prepaid expenses and other current assets 11,566 13,475
Deferred income taxes 1,786 1,789
TOTAL CURRENT ASSETS 295,461 324,841
Property, plant and equipment, net 36,046 35,054
Goodwill 26,698 26,698
Intangible assets 48,656 46,270
Other assets 5,774 7,369
TOTAL ASSETS $ 412,635 $ 440,232
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Current portion of long term debt $ 48,964 $ 48,964
Accounts payable 39,908 53,245
Accrued expenses and other current liabilities 32,576 29,480
Income taxes payable 1,612 1,341
TOTAL CURRENT LIABILITIES 123,060 133,030
Long term debt 92,217 93,733
Deferred income taxes 16,282 16,329
Other liabilities 10,273 9,742
TOTAL LIABILITIES 241,832 252,834
SHAREHOLDERS’ EQUITY
Common stock, no par value 413,092 414,462
Treasury stock, at cost (46,356 ) (46,356 )
Accumulated deficit (197,812 ) (181,972 )
Accumulated other comprehensive income 1,879 1,264
TOTAL SHAREHOLDERS’ EQUITY 170,803 187,398
TOTAL LIABILITIES AND
SHAREHOLDERS’ EQUITY $ 412,635 $ 440,232
* As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.
KULICKE & SOFFA INDUSTRIES, INC.
OPERATING RESULTS BY BUSINESS SEGMENT
(In thousands)
(Unaudited)
Fiscal 2010:
Expendable
Equipment Tools
Three months ended January 2, 2010 Segment Segment Consolidated
Net revenue $ 111,597 $ 16,818 $ 128,415
Cost of sales 65,145 6,897 72,042
Gross profit 46,452 9,921 56,373
Operating expenses 31,605 6,782 38,387
Income from continuing operations $ 14,847 $ 3,139 $ 17,986
Fiscal 2009:
Expendable
Equipment Tools
Three months ended December 27, 2008 * Segment Segment Consolidated
Net revenue $ 23,659 $ 13,757 $ 37,416
Cost of sales 16,657 6,831 23,488
Gross profit 7,002 6,926 13,928
Operating expenses 38,733 6,519 45,252
Income (loss) from continuing operations $ (31,731 ) $ 407 $ (31,324 )
* As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.
KULICKE & SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Three months ended
December 27, 2008 January 2, 2010
Net cash provided by continuing operations $ 2,012 $ 34,125
Net cash used in discontinued operations (779 ) (496 )
Net cash provided by operating activities $ 1,233 $ 33,629
Net cash used in investing activities, continuing operations (48,880 ) (1,031 )
Net cash provided by (used in) investing activities, discontinued operations 149,857 (1,838 )
Net cash provided by (used in) investing activities $ 100,977 $ (2,869 )
Net cash used in financing activities, continuing operations (74,187 ) (23 )
Effect of exchange rate changes on cash and cash equivalents 91 (90 )
Changes in cash and cash equivalents $ 28,114 $ 30,647
Cash and cash equivalents, beginning of period 144,932 144,560
Cash and cash equivalents, end of period $ 173,046 $ 175,207
KULICKE & SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS – SUMMARY
COMPARISON OF GAAP RESULTS TO NON-GAAP MEASURES
(In thousands, except share amounts)
(Unaudited)
Three months ended Three months ended
December 27, January 2,
2008 * 2010
(GAAP results)
Net revenue $ 37,416 $ 128,415
Gross profit 13,928 56,373
Income (loss) from operations (31,324 ) 17,986
Income (loss) from continuing operations (19,588 ) 15,840
Weighted average shares outstanding
Basic 60,451 69,684
Diluted 60,451 73,687
Income (loss) per share from continuing operations
Basic $ (0.32 ) $ 0.23
Diluted $ (0.32 ) $ 0.21
(Non-GAAP measures)
Net revenue $ 37,416 $ 128,415
Gross profit 13,899 56,419
Income (loss) from operations (21,837 ) 21,677
Income (loss) from continuing operations (21,878 ) 21,197
Weighted average shares outstanding
Basic 60,451 69,684
Diluted 60,451 73,687
Income (loss) per share from continuing operations
Basic $ (0.36 ) $ 0.30
Diluted $ (0.36 ) $ 0.29
* As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.
KULICKE & SOFFA INDUSTRIES, INC.
OPERATING RESULTS BY BUSINESS SEGMENT – SUMMARY
COMPARISON OF GAAP RESULTS TO NON-GAAP MEASURES
(In thousands)
(Unaudited)
Expendable
Equipment Tools
Segment Segment Consolidated
Fiscal 2010:
Three months ended January 2, 2010
(GAAP results)
Net revenue $ 111,597 $ 16,818 $ 128,415
Gross profit 46,452 9,921 56,373
Income from operations 14,847 3,139 17,986
(Non-GAAP measures)
Net revenue $ 111,597 $ 16,818 $ 128,415
Gross profit 46,489 9,930 56,419
Income from operations 17,513 4,164 21,677
Fiscal 2009:
Three months ended December 27, 2008 *
(GAAP results)
Net revenue $ 23,659 $ 13,757 $ 37,416
Gross profit 7,002 6,926 13,928
Income (loss) from operations (31,731 ) 407 (31,324 )
(Non-GAAP measures)
Net revenue $ 23,659 $ 13,757 $ 37,416
Gross profit 7,017 6,882 13,899
Income (loss) from operations (26,237 ) 4,400 (21,837 )
KULICKE & SOFFA INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
RECONCILIATION OF GAAP RESULTS TO NON-GAAP MEASURES
(In thousands, except share amounts)
(Unaudited)
Three months ended Three months ended
December 27, % of January 2, % of
2008 * Revenue 2010 Revenue
Net revenue (GAAP results) $ 37,416 $ 128,415
Net revenue (Non-GAAP measures) 37,416 128,415
Gross profit (GAAP results) 13,928 37.2% 56,373 43.9%
– Equity-based compensation expense (29 ) 46
Gross profit (Non-GAAP measures) 13,899 37.1% 56,419 43.9%
Income (loss) from operations (GAAP results) (31,324 ) -83.7% 17,986 14.0%
– Equity-based compensation expense (672 ) 1,104
– Severance plan 2,586 199
– Facilities contractual commitments 2,608
– Tax settlement expense 2,212
– Amortization of intangibles 2,753 2,388
Income (loss) from operations (Non-GAAP measures) (21,837 ) -58.4% 21,677 16.9%
Income (loss) from continuing operations (GAAP results) (19,588 ) -52.4% 15,840 12.3%
– Equity-based compensation expense (672 ) 1,104
– Severance plan 2,586 199
– Facilities contractual commitments 2,608
– Tax settlement expense 2,212
– Amortization of intangibles 2,753 2,388
– Gain on extinguishment of debt (1,179 )
– Non cash interest expense 1,642 1,720
– Tax settlement benefit (12,154 )
– Tax effect of non-GAAP adjustments (86 ) (54 )
Income (loss) from continuing operations (Non-GAAP measures) (21,878 ) -58.5% 21,197 16.5%
Weighted average shares outstanding (GAAP & Non-GAAP)
Basic 60,451 69,684
Diluted 60,451 73,687
Income (loss) per share from continuing operations (GAAP results)
Basic $ (0.32 ) $ 0.23
Diluted $ (0.32 ) $ 0.21
Adjustments to net income (loss) per share
Basic $ (0.04 ) $ 0.07
Diluted $ (0.04 ) $ 0.08
Income (loss) per share from continuing operations (Non-GAAP measures)
Basic $ (0.36 ) $ 0.30
Diluted $ (0.36 ) $ 0.29
* As adjusted for ASC No. 470.20, Debt, Debt With Conversion Options.
KULICKE & SOFFA INDUSTRIES, INC.
OPERATING RESULTS BY BUSINESS SEGMENT
RECONCILIATION OF GAAP RESULTS TO NON-GAAP MEASURES
(In thousands)
(Unaudited)
Expendable
Equipment % of Tools % of
Segment Revenue Segment Revenue Consolidated
Fiscal 2010:
Three months ended January 2, 2010
Net revenue (GAAP results) $ 111,597 $ 16,818 $ 128,415
Net revenue (Non-GAAP measures) 111,597 16,818 128,415
Gross profit (GAAP results) 46,452 41.6 % 9,921 59.0 % 56,373
– Equity-based compensation expense 37 9 46
Gross profit (Non-GAAP measures) 46,489 41.7 % 9,930 59.0 % 56,419
Income from operations (GAAP results) 14,847 13.3 % 3,139 18.7 % 17,986
– Equity-based compensation expense 877 227 1,104
– Severance plan (26 ) 225 199
– Amortization of intangibles 1,815 573 2,388
Income from operations (Non-GAAP measures) 17,513 15.7 % 4,164 24.8 % 21,677
Fiscal 2009:
Three months ended December 27, 2008
Net revenue (GAAP results) $ 23,659 $ 13,757 $ 37,416
Net revenue (Non-GAAP measures) 23,659 13,757 37,416
Gross profit (GAAP results) 7,002 29.6 % 6,926 50.3 % 13,928
– Equity-based compensation expense 15 (44 ) (29 )
Gross profit (Non-GAAP measures) 7,017 29.7 % 6,882 50.0 % 13,899
Income (loss) from operations (GAAP results) (31,731 ) -134.1 % 407 3.0 % (31,324 )
– Equity-based compensation expense (367 ) (305 ) (672 )
– Severance plan 1,600 986 2,586
– Facilities contractual commitments 2,165 443 2,608
– Tax settlement expense 2,212 2,212
– Amortization of intangibles 2,096 657 2,753
Income (loss) from operations (Non-GAAP measures) (26,237 ) -110.9 % 4,400 32.0 % (21,837 )
Reconciliation of Return on Invested Capital
(For the three months ending January 2, 2010)
(Dollar amounts in thousands)
(Unaudited)
As Reported Adjustments Non-GAAP ROIC
GAAP Results
Depreciation/
Amortization
Income from Operations $ 17,986 $ 4,513 $ 22,499 Adjusted Net
Operating Income
X 4
$ 89,996 (A) Annualized
Company FIN 48
Cash Limit (1) Adoption (2)
Cash & Cash
Equivalents & Investments held to Maturity $ 175,423 $ (100,423 ) $ 75,000
Non-Cash Assets $ 264,809 $ 264,809
Total Assets $ 440,232 $ 339,809
Total Current Liabilities $ 133,030 $ 1,699 $ 85,765
Net Invested Capital $ 307,202 $ 254,044 (B) Adjusted Net
Invested Capital
35.4 % (A)/(B) ROIC
(1) Only the first $75 million of cash is used for the ROIC calculation which management estimates is the Company’s minimum cash requirement.
(2) Current liabilities includes tax liabilities classified as current liabilities in prior periods, but reclassified to long term liabilities as a result of the Company’s adopted FIN 48 in fiscal Q1 of 2008.
Thursday, February 4th, 2010 Uncategorized Comments Off on Kulicke & Soffa (KLIC) Reports Results for its First Fiscal Quarter 2010

RiT Technologies (RITT) Reports Q4 and Full Year 2009 Results

Press Release Source: RiT Technologies Ltd On Thursday February 4, 2010, 7:00 am EST

TEL AVIV, Israel, February 4 /PRNewswire-FirstCall/ —

– After Challenging 2009, Company has Accelerated Sales Efforts & Concluded Reorganization and Cost-Cutting Plan

RiT Technologies (NASDAQ: RITT), today announced its financial results for the fourth quarter and full year ended December 31, 2009.

Revenues for the fourth quarter of 2009 were $2.2 million compared with $4.5 million for the fourth quarter of 2008. Net loss for the quarter was $(1.6) million, or $(0.61) per share (basic and diluted), compared with $(0.7) million, or $(0.28) per share (basic and diluted) in the fourth quarter of 2008.

For the twelve month period, revenues were $8.7 million compared with $22.6 million for 2008. Net loss for 2009 was $(6.5) million, or $(2.48) per share (basic and diluted), compared with $(1.2) million, or $(0.59) per share (basic and diluted) for 2008.

Reorganization and Cost-Cutting Plan

Since the end of the third quarter of 2009, RiT has implemented a company-wide reorganization and cost-cutting plan that will reduce the Company’s 2010 operating expenses by approximately $1.7 million compared with their level in 2009.

Comments of Management

“Our 2009 results reflect the recession that has dominated our target construction and financial verticals since late 2008, especially in the territories that are traditionally our strongest, such as Russia, the U.K. and North America,” commented Mr. Avi Kovarsky, RiT’s President & CEO. “In response to the reduced sales, we have accelerated our sales efforts and completed a comprehensive cost-cutting and reorganization program that will reduce our operating expenses by $1.7 million in 2010 as compared with 2009. At this expense level, and with the continued strong financing support of our controlling shareholder Stins Coman, we believe that we have the flexibility we need to pursue growth in step with the recovery of our markets.”

Mr. Kovarsky continued, “At the same time, two positive factors give us room for optimism as we look forward into 2010 and beyond. First, we continue to have a rich sales pipeline, which includes significant late-stage Carrier deals and high-potential Enterprise deals delayed from 2009. Second, we see significant potential in our new SiteWiz and EPV solutions, which expand our reach into the resilient small-to-medium-sized Enterprise segment. We are encouraged by the market reaction to these products and are very near to closing a significant SiteWiz deal. ”

Mr. Kovarsky concluded, “We are encouraged by the combination of these positive factors. With a lean expense structure, a rich sales pipeline, the right products and strong backing, we feel well positioned to achieve a turnaround and to deliver improved results in the year ahead.”

Conference Call Details

    The Company will host a conference call to discuss these results today,
Thursday, February 4th, at:
    10:00 a.m. Eastern Time
    9:00 a.m. Central Time
    8:00 a.m. Mountain Time
    7:00 a.m. Pacific Time
    17:00 Israel Time

To participate, please call one of the following teleconferencing numbers approximately 5-10 minutes prior to the scheduled start of the call:

1-888-407-2553 Toll free for US

+972-3-9180609 – International

To participate in the webcast of the call, please log-in about 5-10 minutes prior to the start of the call as follows: http://www.videonewswire.com/event.asp?id=65771.

For those unable to participate, the teleconference will be archived for replay for 14 days at the same url address, beginning 12 o’clock noon (EST) the day of the call. Note: Participants in the webcast may submit questions to be addressed in the conference call in advance by email to: simonag@rit.co.il, by phone: +972-3-766-4249 or fax: +972-3-647-4115.

About RiT Technologies

RiT is a leading provider of intelligent solutions for infrastructure management, asset management, environment and security, and network utilization. RiT Enterprise solutions address datacenters, communication rooms and workspace environments, ensuring maximum utilization, reliability, decreased downtime, physical security, automated deployment, asset tracking, and troubleshooting. RiT Environment and Security solutions enable companies to effectively control their datacenters, communications rooms and remote physical sites and facilities in real-time, comprehensively and accurately. RiT Carrier solutions provide carriers with the full array of network mapping, testing and bandwidth qualification capabilities needed for access network installation and service provisioning. RiT’s field-tested solutions are delivering value in thousands of installations for top-tier enterprises and operators throughout the world.

For more information, please visit our website: http://www.rittech.com

Safe Harbor Statement

In this press release, all statements that are not purely about historical facts, including, but not limited to, those in which we use the words “believe,” “anticipate,” “expect,” “plan,” “intend,” “estimate”, “forecast”, “target”, “could” and similar expressions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For example, when we discuss a field trial which could lead to a multi-million dollar Carrier deal, we are using a forward looking statement. While these forward-looking statements represent our current judgment of what may happen in the future, actual results may differ materially from the results expressed or implied by these statements due to numerous important factors, including, but not limited to, those described under the heading “Risk Factors” in our most recent Annual Report filed with the Securities and Exchange Commission (SEC) on Form 20-F, which may be revised or supplemented in subsequent reports filed with the SEC. These factors include, but are not limited to, the following: our ability to raise additional financing, if required; the continued development of market trends in directions that benefit our sales; our ability to maintain and grow our revenues; our dependence upon independent distributors, representatives and strategic partners; our ability to develop new products and enhance our existing products; the availability of third-party components used in our products; the economic condition of our customers; the impact of government regulation; and the economic and political situation in Israel. We are under no obligation, and expressly disclaim any obligation, to update the forward-looking statements in this press release, whether as a result of new information, future events or otherwise.

                                                RiT TECHNOLOGIES LTD.
                                      CONSOLIDATED BALANCE SHEETS (U.S GAAP)
                                            (U.S dollars in thousands)

                                  December 31, 2009         December 31, 2008
    Assets                              (Unaudited)                (Audited)
    Current Assets
    Cash and cash equivalents                1,610                     6,111
    Trade receivables, net                   2,044                     3,737
    Other current assets                       462                       536
    Assets held for severance benefits         112                       -
    Inventories                              3,355                     3,978
                                             7,583                     14,362
    Long Term Assets
    Trade receivables, net                     181                       351
    Assets held for severance benefits       1,409                     1,579
                                             1,590                     1,930
    Property and Equipment
    Cost                                     3,252                     3,502
    Less - accumulated depreciation          2,870                     2,958
                                               382                       544

    Total Assets                             9,555                     16,836
    Liabilities and Shareholders' Equity
    Current Liabilities
    Short-term loan                            250                       -
    Trade payables                           1,322                     3,101
    Other payables and accrued expenses      1,340                     2,286
    Liability in respect of employees'
    severance benefits                         143                       -
                                             3,055                     5,387

    Other Liabilities
    Convertible loan from principal
    shareholder                              1,805                     -
    Liability in respect of employees'
     severance benefits                      1,633                     2,076
                                             3,438                     2,076
    Total Liabilities                        6,493                     7,463

    Shareholders' Equity
    Share capital                              559                       559
    Treasury stock                            (27)                      (27)
    Additional paid-in capital              36,820                    36,681
    Accumulated deficit                   (34,290)                  (27,840)
                                             3,062                     9,373
    Total Liabilities and
    Shareholders' Equity                     9,555                     16,836

                       RiT TECHNOLOGIES LTD.
                STATEMENTS OF OPERATIONS (U.S GAAP)

         (U.S dollars in thousands, except per share data)

                                         For the three       For the twelve
                                          months ended        months ended
                                          December 31,        December 31,
                                          (Unaudited)         (Unaudited)

                                        2009       2008       2009       2008
                                      U.S. $     U.S. $     U.S. $     U.S. $

    Sales                              2,214      4,538      8,655     22,556
    Cost of sales                      1,307      2,344      4,710     11,080
    Gross profit                         907      2,194      3,945     11,476

    Operating costs and expenses:
    Research and development:
    Research and development, gross      760        925      3,158      3,781
    Less - royalty-bearing
    participation                        206          -        206        104
    Research and development, net        554        925      2,952      3,677

    Sales and marketing                1,417      1,400      5,268      6,351
    General and administrative           521        556      2,065      2,718
    Total operating expenses           2,492      2,881     10,285     12,746
    Operating loss                   (1,585)      (687)    (6,340)    (1,270)
    Financial income (loss), net         (7)       (39)      (110)         52
    Net Loss                         (1,592)      (726)    (6,450)    (1,218)

    Net loss per ordinary share
    (basic and diluted)               (0.61)     (0.28)     (2.48)     (0.59)

    Weighted average number of
    ordinary shares, used to
    compute net Loss per ordinary
    share (basic and diluted)      2,604,428  2,604,428  2,604,428  2,060,697
Thursday, February 4th, 2010 Uncategorized Comments Off on RiT Technologies (RITT) Reports Q4 and Full Year 2009 Results

MOD-PAC CORP. (MPAC) Earnings per Share Increases 800%

Press Release Source: MOD-PAC CORP. On Thursday February 4, 2010, 10:00 am EST

BUFFALO, N.Y.–(BUSINESS WIRE)–MOD-PAC CORP. (NASDAQ: MPACNews), a manufacturer of custom and stock paper board packaging and personalized print products, today reported total revenue of $12.77 million in the fourth quarter of 2009, which ended December 31, 2009, down 6.2% compared with revenue of $13.62 million in the 2008 fourth quarter. Excluding 2008 fourth quarter specialty print and direct mail sales which was rationalized in the second quarter of 2009, total revenue grew $139 thousand, or 1.1%, compared with the 2008 fourth quarter. Solid 6% sales growth in the custom folding carton line was mostly offset by reduced sales in the stock packaging and personalized print lines which have been impacted by the weak economy.

Net income for the fourth quarter of 2009 was $1.26 million, or $0.36 per diluted share, a significant increase when compared with net income of $129 thousand, or $0.04 per diluted share, in the fourth quarter of 2008. Net income growth reflects the effectiveness of the product line rationalization which eliminated unprofitable business combined with improved productivity and cost reductions.

For the full year 2009, total revenue was relatively unchanged at $48.9 million as 13.7% growth in custom folding cartons offset the impact of six months less sales from the specialty print and direct mail product line and the decline in stock packaging and personalized print sales. Excluding 2009 and 2008 specialty print and direct mail sales, total revenue was $47.4 million for 2009, up $2.7 million, or 6.0%, when compared with $44.7 million for 2008. GAAP net loss for the year was $2.0 million, or $0.58 per diluted share. Excluding $2.0 million in onetime charges associated with the product line rationalization and the write-down of impaired assets, net income would have been $12 thousand, or $0.00 per diluted share. (See reconciliation of GAAP net income (loss) and earnings (loss) per share to adjusted net income (loss) and earnings (loss) per share in the attached table.)

Fourth Quarter 2009 Sales Review:

  • Sales of folding cartons, which include custom folding cartons and stock packaging, were up 2.5%, or $0.29 million, to $12.03 million in the 2009 fourth quarter from $11.74 million in the prior year fourth quarter. Custom folding carton sales drove the product line increase.
  • Custom folding carton sales for the fourth quarter of 2009 were $8.96 million, up $0.51 million, or 6.0%, from 2008 fourth quarter sales of $8.46 million. Sales growth was driven by continued sales growth with existing customers, particularly those that provide private label branded products.
  • Stock packaging sales were $3.07 million in the 2009 fourth quarter, a decline of $0.22 million, or 6.6%, from $3.28 million the prior year period. The stock packaging line has been impacted by economic conditions over the last year.
  • Print service sales, which are now solely comprised of personalized print, were down
    $1.15 million, or 65.9%, to $0.60 million in the 2009 fourth quarter compared with $1.75 million in the same period in 2008. Of the decline, $0.99 million was related to sales in the prior year’s fourth quarter for specialty print and direct mail. Personalized print sales declined
    $165 thousand, or 21.6%, to $0.60 million in the fourth quarter of 2009 compared with sales of $0.76 million in last year’s fourth quarter. The decrease was primarily due to current economic conditions.

Mr. Daniel G. Keane, President and CEO of MOD-PAC CORP., commented, “The rationalization of the specialty print and direct mail product line has enabled us to focus our resources on expanding our custom folding carton business. We believe our ability to provide on demand short runs of customized cartons for our customers is a cost effective means for them to address their customers changing requirements.”

Fourth Quarter Operating Results: Cost discipline and product line rationalization drove margin expansion

Gross profit for the 2009 fourth quarter was $2.98 million, or 23.4% of total revenue, compared with gross profit of $2.12 million, or 15.6% of total revenue, in the same period the prior year. The improvement in gross profit and margin was driven by the savings realized from the product line rationalization as the Company realized lower depreciation expense and decreased labor and supply costs. Also contributing to the improved margin was lower freight and utility costs and improvements in productivity.

Selling, general and administrative (SG&A) expense was down $126 thousand, or 6.7%, to $1.75 million, or 13.7% of total revenue, in the fourth quarter of 2009 when compared with $1.88 million, or 13.8% of total revenue, in the same period the prior year. The decrease was due to lower wages from the product line rationalization, reduced professional service fees, and lower bad debt expense.

Mr. David B. Lupp, Chief Operating Officer and Chief Financial Officer commented, “Having rationalized product lines and increased our focus on our core products, we are now driving a leaner, more productive operation. We have made several operational improvements that have increased our productivity enabling us to strengthen our earnings power. We believe that we can continue to build efficiencies and grow sales by targeting customers that value our quality, speed and value-based pricing.”

Adjusted earnings before interest, asset impairment, taxes, depreciation and amortization, and non-cash option expense (Adjusted EBITDA) was $2.03 million in the fourth quarter of 2009 compared with $1.23 million in the 2008 fourth quarter. The Company believes that, when used in conjunction with GAAP measures, Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of operating performance. (See the reconciliation of Net Income (loss) to Adjusted EBITDA in the attached table.)

As required by generally accepted accounting principles, in the second quarter of 2009 the Company recorded a full valuation allowance on its net deferred tax asset due to the uncertainty with respect to utilizing it in the future based on a past trend of operating losses. As a result, the effective tax rate for the fourth quarter of 2009 was 0%, compared with 43.2% for the fourth quarter of 2008. The Company has approximately $0.64 million in net operating loss carry forwards that can be applied to future income.

Liquidity: Asset sales and strong cash generation from operations increased cash on hand

Cash and cash equivalents were $3.78 million at December 31, 2009, a substantial increase compared with $0.32 million at October 3, 2009 and $0.20 million at December 31, 2008. MOD-PAC generated $2.26 million in cash from operations during the quarter from higher net income, higher non-cash depreciation and amortization expense, and decreased working capital requirements. Also, in the fourth quarter of 2009, the Company sold its Blasdell, NY facility for net proceeds of $1.4 million and assets related to the specialty print and direct mail rationalization for approximately $0.6 million.

Capital expenditures in the fourth quarter and full year of 2009 were $0.13 million and $0.98 million, respectively, compared with $0.39 million and $2.0 million, in the same periods the prior year. Capital spending was focused on equipment and system improvements. Approximately half of the capital expenditures in 2008 were for productivity and efficiency initiatives that provided a benefit to the organization in 2009. Capital expenditures are expected to be approximately $1.2 million in fiscal year 2010. Depreciation and amortization was $3.19 million in 2009 compared with $3.74 million in 2008. Lower depreciation primarily reflects a reduced asset base from the write-down of assets associated with the rationalized product line in the second quarter of 2009.

MOD-PAC has access to a $5.0 million committed line of credit with a commercial bank, which expires in March 2010. The line of credit was paid off in full in the fourth quarter of 2009, a decrease of $0.6 million from the October 3, 2009 balance, and $1.0 million from the December 31, 2008 balance. An additional $0.2 million of the line of credit was in use through standby letters of credit. The Company is currently in negotiations with several financial organizations regarding a new line of credit.

There were no shares repurchased by the Company in 2009. MOD-PAC has authorization to repurchase 75,885 shares.

Year-End Review: 13.7% growth in custom folding carton sales; Excluding one time charges achieves breakeven on flat sales

Total revenue for 2009 was flat with 2008 at $48.90 million. Net sales, excluding rent, for the same period was down slightly to $48.35 million, compared with $48.41 million in 2008. New customers and gaining additional business from existing customers drove the 13.7% growth in custom folding carton sales to $34.85 million compared with $30.65 million in the prior year. Economic conditions continued to negatively impact stock packaging and personalized print sales, which were down 7.4% to $8.95 million, and 22.4% to $3.03 million, respectively, in 2009 when compared with 2008 results.

In 2008, specialty print and direct mail had $4.19 million in sales. This product line had $1.52 million in sales during the first half of 2009.

Gross profit for 2009 was $7.38 million, or 15.1% of total revenue, up $0.65 million, or 9.7%, from gross profit of $6.72 million, or 13.8% of total revenue, in 2008. Increases in gross profit dollars and margin expansion reflect the effectiveness of rationalizing product lines and eliminating losses associated with specialty print and direct mail as well as process improvements that are driving productivity gains.

SG&A expense in 2009 decreased 4.1% to $7.55 million, or 15.4% of total revenue, compared with $7.87 million, or 16.1% of total revenue, in 2008. The decrease was due to lower professional service fees, reduced advertising, and lower bad debt expense, slightly offset by higher commission and depreciation expense.

Included in the 2009 results was $1.8 million of expense that was associated with the write-down of impaired assets due to the Company’s rationalization of the specialty print and direct mail product line.

Adjusted EBITDA for 2009 was up to $3.51 million compared with $2.99 million in 2008. (See the reconciliation of Net Income (loss) to Adjusted EBITDA in the attached table.)

Mr. Lupp concluded, “We have successfully completed the turn around of our operations that provides a solid platform from which we can grow. Our strategy is to continue to further penetrate the custom folding carton market, specifically in the niche applications where our rapid turn around, high quality carton design, and responsive service address the unique needs of our customers that serve a broad variety of customers needing smaller print quantities. We are also evaluating opportunities to expand the markets served with our personalized print and stock packaging products while focusing our products and services to improve efficiencies.”

Webcast and Conference Call

The release of the financial results will be followed today by a company-hosted teleconference and webcast at 1:30 p.m. Eastern Time. During the teleconference, Daniel G. Keane, President and Chief Executive Officer, and David B. Lupp, Chief Operating Officer and Chief Financial Officer, will review the financial and operating results for the period and discuss MOD-PAC CORP.’s corporate strategy and outlook. A question-and-answer session will follow.

The MOD-PAC conference call can be accessed the following ways:

  • The live webcast can be found at http://www.modpac.com. Participants should go to the website 10 – 15 minutes prior to the scheduled conference in order to register and download any necessary audio software.
  • The teleconference can be accessed by dialing (201) 689-8562 and requesting Conference ID Number 340781 approximately 5 – 10 minutes prior to the call.

The archived webcast will be at http://www.modpac.com. A transcript will also be posted once available. A replay can also be heard by calling (201) 612-7415 and entering conference ID number 340781 and account number 3055. The telephonic replay will be available from 4:30 p.m. Eastern Time the day of the teleconference through 11:59 p.m. Eastern Time on February 11, 2010.

ABOUT MOD-PAC CORP.

MOD-PAC CORP. is a high value-added, on demand print services firm providing products and services in two product categories: folding cartons and personalized print. Within folding cartons, MOD-PAC provides CUSTOM FOLDING CARTONS for branded and private label consumer products in the food and food service, healthcare, medical and automotive industries. The Company also offers a line of STOCK PACKAGING primarily to the retail confectionary industry. MOD-PAC’s PERSONALIZED PRINT product line is a comprehensive offering for consumer and corporate social occasions.

MOD-PAC’s strategy for growth is to leverage its capabilities to innovate and aggressively integrate technology into its production operations providing cost-effective solutions for its customers. Through its large, centralized facility, the Company has captured significant economies of scale by channeling large numbers of small-to-medium-sized orders through its operations due to its rapid order change out skills. Applying its lean manufacturing processes coupled with state-of-the-art printing technologies, MOD-PAC is able to address short-run, highly variable content needs of its customers with quick turn around times relative to industry standards.

Additional information on MOD-PAC can be found at its website: http://www.modpac.com.

Safe Harbor Statement: This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. One can identify these forward-looking statements by the use of the words such as “expect,” “anticipate,” “plan,” “may,” “will,” “estimate” or other similar expressions. Because such statements apply to future events, they are subject to risks and uncertainties that could cause the actual results to differ materially. Important factors, which could cause actual results to differ materially, include market events, competitive pressures, changes in technology, customers preferences and choices, success at entering new markets, the execution of its strategy, marketing and sales plans, the rate of growth of internet related sales, the effectiveness of agreements with print distributors and other factors which are described in MOD-PAC’s annual report on Form 10K on file with the Securities and Exchange Commission. The Company assumes no obligation to update forward-looking information in this press release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

FINANCIAL TABLES FOLLOW.

MOD-PAC CORP.

CONSOLIDATED INCOME STATEMENT DATA

(unaudited)
(in thousands except per share data)
Three months ended Year ended
12/31/2009 12/31/2008 12/31/2009 12/31/2008
Revenue
Product sales $ 12,626 $ 13,490 $ 48,353 $ 48,412
Rent 144 130 543 486
Total Revenue 12,770 13,620 48,896 48,898
Cost of products sold 9,786 11,499 41,518 42,174
Gross profit 2,984 2,121 7,378 6,724
Gross profit margin 23.4 % 15.6 % 15.1 % 13.8 %
Selling, general and administrative expense 1,750 1,876 7,549 7,870
(Write-up) Write-down of impaired assets (36 ) 0 1,772 0
Income (Loss) from operations 1,270 245 (1,943 ) (1,146 )
Operating margin 9.9 % 1.8 % -4.0 % -2.3 %
Interest expense, net 51 63 245 266
Other income 45 45 88 138
Income (Loss) before taxes 1,264 227 (2,100 ) (1,274 )
Income tax expense (benefit) 0 98 (118 ) (379 )
Net income (loss) $ 1,264 $ 129 $ (1,982 ) $ (895 )
Basic earnings (loss) per share: $ 0.37 $ 0.04 $ (0.58 ) $ (0.26 )
Diluted earnings (loss) per share: $ 0.36 $ 0.04 $ (0.58 ) $ (0.26 )
Weighted average diluted shares outstanding 3,534 3,450 3,430 3,434
MOD-PAC CORP.
PRODUCT LINE REVENUE DATA
(unaudited)
($, in thousands)
Three Months Ended % Year Ended % 2009 % of
12/31/2009 12/31/2008 change 12/31/2009 12/31/2008 change Total
FOLDING CARTONS
Custom folding cartons $ 8,963 $ 8,458 6.0 % $ 34,851 $ 30,647 13.7 % 72.1 %
Stock packaging 3,065 3,280 -6.6 % 8,953 9,672 -7.4 % 18.5 %
Folding cartons subtotal 12,028 11,738 2.5 % 43,804 40,319 8.6 % 90.6 %
PRINT SERVICES
Specialty print & direct mail 0 989 -100.0 % 1,519 4,190 -63.7 % 3.1 %
Personalized 598 763 -21.6 % 3,030 3,903 -22.4 % 6.3 %
Print services subtotal 598 1,752 -65.9 % 4,549 8,093 -43.8 % 9.4 %
Total product revenue $ 12,626 $ 13,490 -6.4 % $ 48,353 $ 48,412 -0.1 % 100.0 %
MOD-PAC CORP.

CONSOLIDATED BALANCE SHEET DATA

(dollars in thousands)
December 31, 2009 December 31, 2008
(Unaudited)
Current assets:
Cash and cash equivalents $ 3,780 $ 200
Trade accounts receivable, net of allowance
of $155 in 2009 and $170 in 2008 4,820 4,750
Inventories 4,258 4,313
Prepaid expenses 297 357
Total current assets 13,155 9,620
Property, plant and equipment, at cost 63,678 68,707
Less accumulated depreciation (48,262 ) (47,116 )
Net property, plant and equipment 15,416 21,591
Assets held for sale 171
Other assets 459 1,340
Totals assets $ 29,201 $ 32,551
Current liabilities:
Current maturities of long-term debt $ 202 $ 168
Accounts payable 2,567 3,222
Accrued expenses 803 581
Total current liabilities 3,572 3,971
Line of credit 1,000
Long-term debt 2,292 2,413
Other liabilities 38 37
Deferred income taxes 118
Total liabilities $ 5,902 $ 7,539
Shareholders’ equity:
Common stock, $.01 par value
Authorized 20,000,000 shares, issued
3,453,863 in 2009, 3,439,347 in 2008 35 34
Class B common stock, $.01 par value
Authorized 5,000,000 shares, issued
628,385 in 2009, 641,482 in 2008 6 7
Additional paid-in capital 2,654 2,385
Retained earnings 26,819 28,801
29,514 31,227
Less treasury shares, at cost 650,698 in
2009 and 2008 (6,215 ) (6,215 )
Total shareholders’ equity 23,299 25,012
Total liabilities and shareholders’ equity $ 29,201 $ 32,551
MOD-PAC CORP.

CONSOLIDATED STATEMENT OF CASH FLOWS

(dollars in thousands)
(Unaudited)
Year Ended
December 31,2009 December 31,

2008

Cash flows from operating activities:
Net loss $ (1,982 ) $ (895 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 3,188 3,737
Provision for doubtful accounts 20 108
Stock option compensation expense 265 256
Deferred income taxes (118 ) (381 )
Net write-down of impaired assets 1,772
Loss (Gain) on disposal of assets 15 (54 )
Cash flows from changes in operating assets and liabilities
Accounts receivable (90 ) (602 )
Inventories 55 (772 )
Prepaid expenses 60 (98 )
Other liabilities 1 (232 )
Accounts payable (655 ) 310
Accrued expenses 222 (234 )
Net cash provided by operating activities 2,753 1,143
Cash flows from investing activities:
Proceeds from the sale of assets 2,190 125
Proceeds from the cash surrender value of officers’ life insurance policies 857
Change in other assets (78 ) (80 )
Capital expenditures (975 ) (1,993 )
Net cash provided by (used in) investing activities 1,994 (1,948 )
Cash flows from financing activities:
Principal payments on long-term debt (171 ) (118 )
(Decrease) increase in line of credit (1,000 ) 600
Proceeds from loans 580
Proceeds from issuance of stock 4
Purchase of treasury stock (150 )
Deferred financing fees (5 )
Net cash (used in) provided by financing activities (1,167 ) 907
Net increase in cash and cash equivalents 3,580 102
Cash and cash equivalents at beginning of year 200 98
Cash and cash equivalents at end of period $ 3,780 $ 200
MOD-PAC CORP.
Reconciliation between GAAP Net Income (Loss) and Adjusted Net Income (Loss)
(in thousands) Three Months Ended Year Ended
12/31/2009 6/28/2008 12/31/2009 12/31/2008
GAAP Net Income (Loss) $ 1,264 $ 129 $ (1,982 ) $ (895 )
(Write-up) Write-down of impaired assets (36 ) 0 1,772 0
Workforce reduction 0 0 65 0
Change in useful life of assets 0 0 40 0
Other rationalization charges 0 0 117 0
Total one-time charges (36 ) 0 1,994 0
Adjusted Net Income (Loss) $ 1,228 $ 129 $ 12 $ (895 )
MOD-PAC CORP.
Reconciliation between GAAP Diluted Earnings (Loss) per Share and
Adjusted Diluted Earnings (Loss) Per Share
Three Months Ended Year Ended
12/31/2009 12/31/2008 12/31/2009 12/31/2008
GAAP Diluted Earnings (Loss) Per Share $ 0.36 $ 0.04 $ (0.58 ) $ (0.30 )
(Write-up) Write-down of impaired assets (0.01 ) 0 0.52 0
Workforce reduction 0 0 0.02 0
Change in useful life of assets 0 0 0.01 0
Other rationalization charges 0 0 0.03 0
Total one-time charges (0.01 ) 0 0.58 0
Adjusted Diluted Earnings (Loss) Per Share $ 0.35 $ 0.04 $ 0.00 $ (0.30 )
MOD-PAC CORP.
Reconciliation between GAAP Net Income or Loss and Adjusted EBITDA
(in thousands) Three Months Ended Year Ended
12/31/2009 12/31/2008 12/31/2009 12/31/2008
GAAP Net Income (Loss) $ 1,264 $ 129 $ (1,982 ) $ (895 )
Interest 51 63 245 266
Write-down of impaired assets 0 0 1,912 0
Taxes 0 98 (118 ) (379 )
Depreciation and amortization 658 887 3,188 3,737
Stock-based compensation 55 49 265 256
Adjusted EBITDA $ 2,028 $ 1,226 $ 3,510 $ 2,985
Adjusted EBITDA = earnings before interest, asset impairment, taxes, depreciation and amortization and non-cash option expense.

Thursday, February 4th, 2010 Uncategorized Comments Off on MOD-PAC CORP. (MPAC) Earnings per Share Increases 800%

NetLogic Microsystems (NETL) Announces Fourth Quarter 2009 Financial Results

Feb. 2, 2010 (Business Wire) — NetLogic Microsystems, Inc. (NASDAQ:NETL), a worldwide leader in high performance intelligent semiconductor solutions for next-generation Internet networks, today announced financial results for its fourth quarter ended Dec. 31, 2009.

Revenue for the fourth quarter of 2009 was $69.5 million, a 64.3% sequential increase from $42.3 million for the third quarter of 2009 and a 125% increase from $30.9 million for the fourth quarter of 2008.

Revenue for fiscal year 2009 was $174.7 million, a 24.8% increase from $139.9 million for fiscal year 2008.

Fourth quarter 2009 net loss, determined in accordance with generally accepted accounting principles (GAAP), was $37.2 million or $1.43 per diluted share. By comparison, GAAP net loss was $1.1 million or $0.05 per diluted share for the fourth quarter of 2008. GAAP net loss for fourth quarter 2009 included stock-based compensation expense, changes in contingent earn-out liability, amortization of intangible assets, fair value inventory adjustments, acquisition-related costs, interest income on a $15.0 million bridge loan to RMI Corporation, debt issuance cost write-off, tax effect of inventory fair value adjustments and adjustment charges related to certain tax reserves relating to an intercompany license agreement. Excluding these items, non-GAAP net income for the fourth quarter of 2009 was $17.5 million or $0.59 per diluted share, compared with $0.31 per diluted share for the fourth quarter of 2008.

Fiscal year 2009 GAAP net loss was $47.2 million or $2.04 per diluted share. By comparison, GAAP net income was $3.6 million or $0.16 per diluted share for fiscal year 2008. GAAP net loss for fiscal year 2009 included stock-based compensation expense, changes in contingent earn-out liability, amortization of intangible assets, fair value inventory adjustments, acquisition-related costs, interest income on a $15.0 million bridge loan to RMI Corporation, debt issuance cost write-off, establishment of deferred tax asset valuation allowance on a portion of the Company’s California research and development credit carryforward, tax effect of inventory fair value adjustments and adjustment charges related to certain tax reserves relating to an intercompany license agreement. Excluding these items, non-GAAP net income for fiscal year 2009 was $43.6 million or $1.73 per diluted share, compared with $1.51 per diluted share for fiscal year 2008.

Cash and cash equivalents totaled $44.3 million as of Dec. 31, 2009. In Dec., the company raised $29.7 million in cash from issuing 700,400 common shares and repaid all outstanding balances under a credit facility with a syndication of banks.

Management Qualitative Comments

“2009 was truly a transformative year for the company,” said Ron Jankov, president and CEO. “Outstanding engineering achievement in our knowledge-based processor and physical layer solutions allowed us to achieve record numbers of design wins, unprecedented competitive positioning and a further extension of our technology leadership. In addition, 2009 marked a major step in the company’s growth with our successful merger with RMI Corporation, a technology leader and true innovator in the rapidly emerging high-end multi-core processor market and the ultra-low power embedded processor market. The integration of our companies is proceeding very smoothly and we are excited about the opportunities that the merger has presented for us to integrate our best-in-class physical layer products, knowledge-based processors and multi-core processors into highly-advanced platform-level solutions. This capability is a significant competitive advantage and will further strengthen our customers’ ability to develop next-generation equipment to support the expected exponential growth in converged IP traffic.”

Recent Highlights

  • The company announced the NL11K processor, the world’s first knowledge-based processor with high-speed serial interface, and a member of its sixth-generation knowledge-based processor family. The integration of high-speed serial interface delivers 225Gbps of raw chip-to-chip interconnect bandwidth. This represents a 340 percent increase in I/O bandwidth-per-pin to enable significantly higher system performance, higher system density and lower system costs for next-generation systems to enable significantly richer services for LTE, IPTV and IPv6 services. In addition, the NL11K processor features an enhanced knowledge-based processing core capable of achieving 1.6 billion decisions per second.
  • NetLogic Microsystems was awarded its 400th United States patent. Its portfolio includes over 600 worldwide patent issuances and pending filings. These achievements mark a significant milestone in the company’s history of being at the forefront of technological and innovation leadership in high-performance semiconductor solutions that perform highly differentiated tasks for advanced 3G/4G mobile wireless infrastructure, data center, enterprise, metro Ethernet, edge and core infrastructure networks.
  • The company took part in the Consumer Electronics Show 2010, demonstrating several new products in its Alchemy® family of ultra low-power embedded processors. The company also announced that it was recently awarded several design wins with leading customers, including Samsung Electronics, SHARP Electronics and Tinnos.
  • The company received the “Most Respected Emerging Public Semiconductor Company Award” for 2009 from the Global Semiconductor Alliance (GSA). This prestigious award recognized NetLogic Microsystems for its vision, strategy, leadership and success in the semiconductor industry among its peers of public semiconductor companies with annual revenues of up to $500 million.
  • The company continues to expand its physical layer product portfolio and recently announced production availability of its new NLP1220 dual-port FibreChannel PHY device. This device offers best-in-class power consumption and latency to customers developing next-generation data center switches and connected storage devices. It was selected by Fujitsu Technology Solutions during the fourth quarter for Fujitsu’s next-generation data center blade solutions.
  • The company’s Au1300® processor, the latest member of its ultra low-power Alchemy processor family, has been selected by LG Electronics for LG’s high-performance automotive infotainment solutions. LG’s market-leading infotainment solutions include built-in audio/video navigation (AVN) for dashboard and rear-seat entertainment (RSE) systems.
  • NetLogic Microsystems completed its merger with RMI Corporation, a leading provider of high-performance and low-power multi-core, multi-threaded processors. The merger enables NetLogic Microsystems to further expand into the high-performance “data-in-flight” processing market. RMI’s cutting-edge XLPTM, XLR® and XLS® Multi-Core, Multi-Threaded Processors will complement NetLogic Microsystems’ existing portfolio of knowledge-based processors, content processors, network search engines and 10-100 Gigabit Ethernet PHY products.

Conference Call

NetLogic Microsystems will hold its fourth quarter 2009 financial results conference call today at 1:30 p.m. Pacific time. To listen to the conference call, dial (866) 202-0886 ten minutes prior to the start of the call, using the passcode 13125832. International callers, dial (617) 213-8841. A taped replay will be made available approximately two hours after the conclusion of the call and will remain available for one week. To access the replay, dial (888) 286-8010 and enter passcode 12270603. International callers dial (617) 801-6888.

The conference call will be available via a live webcast on the investor relations section of NetLogic Microsystems’ web site at http://www.netlogicmicro.com. Access the web site 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the web site for three months.

About NetLogic Microsystems

NetLogic Microsystems, Inc. (NASDAQ: NETL) is a worldwide leader in high-performance intelligent semiconductor solutions that are powering next-generation Internet networks. NetLogic Microsystems’ best-in-class products perform highly differentiated tasks of accelerating complex network traffic to significantly enhance the performance and functionality of advanced 3G/4G mobile wireless infrastructure, data center, enterprise, metro Ethernet, edge and core infrastructure networks. NetLogic Microsystems’ market-leading product portfolio includes high-performance multi-core processors, knowledge-based processors, content processors, network search engines, ultra low-power embedded processors and high-speed 10/40/100 Gigabit Ethernet PHY solutions. These products are designed into high-performance systems such as switches, routers, wireless base stations, security appliances, networked storage appliances, service gateways and connected media devices offered by leading original equipment manufacturers (OEMs). NetLogic Microsystems is headquartered in Mountain View, California, and has offices and design centers throughout North America, Asia and Europe. For more information about products offered by NetLogic Microsystems, call +1-650-961-6676 or visit the NetLogic Microsystems Web site at http://www.netlogicmicro.com.

NetLogic Microsystems, the NetLogic Microsystems logo and XLP are trademarks of NetLogic Microsystems, Inc. Alchemy, Au1300, XLR and XLS are registered trademarks of NetLogic Microsystems, Inc. All other trademarks are the properties of their respective owners.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding NetLogic Microsystems’ business which are not historical facts may be “forward-looking statements” that involve risks and uncertainties. Forward-looking statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Actual results and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety of factors. These factors include, but are not limited to, customer acceptance and demand for our products, the volume of sales to our principal product customers, the timing of our receipt of customer orders during the quarter, manufacturing yields for our products, the timing of manufacture and delivery of product by our foundry suppliers, potential warranty claims and product defects, the length of our sales cycles, our average selling prices, our ability to successfully develop and sell new products, the effects of any business acquisitions that we might make, the strength of the OEM networking equipment market and the cyclical nature of that market and the semiconductor industry. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s reports on Forms 10-K and 10-Q, as well as other reports that NetLogic Microsystems files from time to time with the Securities and Exchange Commission which are available at http://www.sec.gov. All forward-looking statements are qualified in their entirety by this cautionary statement, and NetLogic Microsystems undertakes no obligation to update publicly any forward-looking statement for any reason, except as required by law, even as new information becomes available or other events occur in the future.

NETLOGIC MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT FOR PER SHARE AMOUNTS)

(UNAUDITED)

Three months ended Twelve months ended
December 31,2009 December 31,2008 December 31,2009 December 31,2008
Revenue $ 69,524 $ 30,893 $ 174,689 $ 139,927
Cost of revenue* 50,222 13,449 99,251 61,616
Gross profit 19,302 17,444 75,438 78,311
Operating expenses:
Research and development* 31,210 13,415 73,631 51,607
Selling, general and administrative* 22,019 6,663 43,931 26,567
Change in contingent earn-out liability 2,008 2,008
Acquisition-related costs 2,652 5,412
Total operating expenses 57,889 20,078 124,982 78,174
Income (loss) from operations (38,587 ) (2,634 ) (49,544 ) 137
Interest and other income, net (901 ) 355 (678 ) 1,503
Income (loss) before income taxes (39,488 ) (2,279 ) (50,222 ) 1,640
Benefit from income taxes (2,252 ) (1,141 ) (3,060 ) (1,937 )
Net income (loss) $ (37,236 ) $ (1,138 ) $ (47,162 ) $ 3,577
Net income (loss) per share – Basic $ (1.43 ) $ (0.05 ) $ (2.04 ) $ 0.17
Net income(loss) per share – Diluted $ (1.43 ) $ (0.05 ) $ (2.04 ) $ 0.16
Shares used in calculation – Basic 26,124 21,703 23,091 21,472
Shares used in calculation – Diluted 26,124 21,703 23,091 22,314
* Includes the following amounts of stock-based compensation and related payroll taxes (in thousands):
Three months ended Twelve months ended
December 31,2009 December 31,2008 December 31,2009 December 31,2008
Cost of revenue $ 153 $ 193 $ 672 $ 1,030
Research and development 12,430 2,940 21,775 9,474
Selling, general and administrative 11,815 1,802 18,721 5,988
Total $ 24,398 $ 4,935 $ 41,168 $ 16,492

Non-GAAP Financial Information

In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (GAAP), this announcement of operating results contains non-GAAP financial measures that exclude the income statement effects of stock-based compensation and related payroll taxes, changes in contingent earn-out liability, amortization of intangible assets, fair value adjustments of acquired inventory, acquisition-related costs, interest income on a bridge loan to RMI Corporation, debt issuance cost write-off, deferred tax asset valuation allowance on a portion of the Company’s California research and development credit carryforward, the tax effect of inventory fair value adjustments and adjustment charges related to certain tax reserves relating to an intercompany license agreement, and the effects of excluding stock-based compensation upon the number of diluted shares used in calculating non-GAAP earnings per share.

We have excluded stock-based compensation expense and changes in contingent earn-out liability in calculating these non-GAAP financial measures. These expenses are non-cash in nature and rely on valuations based on future events such as the market price of our common stock and revenue generated from products acquired in the RMI acquisition during the first 12 months following the close that are difficult to predict and are affected by market factors that are largely not within the control of management. We have excluded amortization of intangibles, fair value adjustments related to acquired inventory, acquisition-related costs, interest income on RMI bridge note, debt issuance cost write-off, deferred tax asset valuation allowance on a portion of the Company’s California research and development credit carryforward, tax effect of inventory fair value adjustments, adjustment charges related to certain tax reserves relating to an intercompany license agreement because we do not consider them to be related to our core operating performance.

We use the non-GAAP financial measures that exclude these items to make strategic decisions, forecast future results and evaluate the Company’s current performance. We believe that the presentation of non-GAAP financial measures that exclude these items is useful to investors because we do not consider these charges either part of the day-to-day business or reflective of the core operational activities of the Company that are within the control of management or that are used to evaluate management’s operating performance.

The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures. For additional information regarding these non-GAAP financial measures, and management’s explanation of why it considers such measures to be useful, refer to the Form 8-K dated February 2, 2010 that the Company has submitted to the Securities and Exchange Commission.

NETLOGIC MICROSYSTEMS, INC.

RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME

(IN THOUSANDS)

(UNAUDITED)

Three months ended Twelve months ended
December 31,

2009

December 31,2008 December 31,2009 December 31,2008
GAAP net income (loss) $ (37,236 ) $ (1,138 ) $ (47,162 ) $ 3,577
Reconciling items:
Stock-based compensation and related payroll taxes 24,398 4,935 41,168 16,492
Changes in contingent earn-out liability 2,008 2,008
Amortization of intangible assets 8,851 3,325 20,624 13,300
Fair value adjustment related to the acquired inventory 18,097 47 20,359 1,470
Acquisition-related costs 2,652 5,412
Debt issuance cost written off 524 524
Interest income on RMI bridge note (125 ) (625 )
Tax effect of inventory fair value adjustment (5,349 ) (5,349 )
Adjustments to certain tax reserves related to an intercompany license agreement 3,646 3,646
Establishment of deferred tax asset valuation allowance on a portion of the Company’s California research and development credit carryforward 2,988
Non-GAAP net income $ 17,466 $ 7,169 $ 43,593 $ 34,839
NETLOGIC MICROSYSTEMS, INC.

RECONCILIATION OF GAAP DILUTED NET INCOME (LOSS) PER SHARE TO

NON-GAAP DILUTED NET INCOME PER SHARE

(UNAUDITED)

Three months ended Twelve months ended
December 31,2009 December 31,2008 December 31,2009 December 31,2008
GAAP net income (loss) per share – Diluted $ (1.43 ) $ (0.05 ) $ (2.04 ) $ 0.16
Reconciling items:
Stock-based compensation and related payroll taxes 0.83 0.21 1.63 0.72
Changes in contingent earn-out liability 0.07 0.08
Amortization of intangible assets 0.30 0.14 0.82 0.58
Fair value adjustment related to the acquired inventory 0.62 0.00 0.81 0.06
Acquisition-related costs 0.09 0.21
Debt issuance cost written off 0.02 0.02
Interest income on RMI bridge note (0.00 ) (0.02 )
Tax effect of inventory fair value adjustment (0.18 ) (0.21 )
Adjustments to certain tax reserves related to an intercompany license agreement 0.12 0.14
Establishment of deferred tax asset valuation allowance on a portion of the Company’s California research and development credit carryforward 0.12
Difference in shares count between diluted GAAP and diluted non-GAAP calculation 0.16 0.00 0.17 (0.01 )
Non-GAAP net income per share – Diluted $ 0.59 $ 0.31 $ 1.73 $ 1.51
NETLOGIC MICROSYSTEMS, INC.

RECONCILIATION OF THE SHARES USED FOR GAAP DILUTED

NET INCOME (LOSS) PER SHARE CALCULATION TO THE SHARES USED FOR

NON-GAAP DILUTED NET INCOME PER SHARE CALCULATION

(IN THOUSANDS)

(UNAUDITED)

Three months ended Twelve months ended
December 31,

2009

December 31,2008 December 31,2009 December 31,2008
Shares used in calculation – Diluted (GAAP) 26,124 21,703 23,091 22,314
The effect of removing stock-based compensation expense under FAS 123(R) for Non-GAAP presentation purpose 1,439 842 908 735
The effect of dilutive potential common shares due to reporting non-GAAP net income 1,798 507 1,213
Shares used in calculation – Diluted (Non-GAAP) 29,361 23,052 25,212 23,049
NETLOGIC MICROSYSTEMS, INC.

RECONCILIATION OF GAAP GROSS MARGIN TO NON-GAAP GROSS MARGIN

(IN THOUSANDS, EXCEPT PERCENTAGES)

(UNAUDITED)

Three months ended Twelve months ended
December 31,2009 December 31,2008 December 31,2009 December 31,2008
Total GAAP gross margin $ 19,302 27.8 % $ 17,444 56.5 % $ 75,438 43.2 % $ 78,311 56.0 %
Reconciling items:
Stock-based compensation 153 0.2 % 193 0.6 % 672 0.4 % 1,030 0.7 %
Amortization of intangible assets 8,127 11.7 % 2,980 9.6 % 18,865 10.8 % 11,920 8.5 %
Fair value adjustment related to acquired inventory 18,097 26.0 % 47 0.2 % 20,359 11.7 % 1,470 1.1 %
Total Non-GAAP gross margin $ 45,679 65.7 % $ 20,664 66.9 % $ 115,334 66.0 % $ 92,731 66.3 %
NETLOGIC MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

(UNAUDITED)

December 31,2009 December 31,2008
ASSETS
Current assets:
Cash and cash equivalents $ 44,278 $ 83,474
Short-term investments 13,067
Accounts receivables, net 25,137 8,382
Inventories 45,113 13,707
Deferred income taxes 13,157 3,217
Prepaid expenses and other current assets 8,638 1,937
Total current assets 136,323 123,784
Property and equipment, net 13,278 5,513
Goodwill 112,918 68,712
Intangible asset, net 223,345 39,538
Other assets 46,247 8,224
Total assets $ 532,111 $ 245,771
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable $ 17,937 $ 7,618
Accrued liabilities 34,165 25,920
Contingent earn-out liability 11,727
Deferred margin 2,667 1,638
Software licenses and other obligations, current 3,037 755
Total current liabilities 69,533 35,931
Software licenses and other obligations, long-term 2,409 464
Other liabilities 34,214 9,109
Total liabilities 106,156 45,504
Stockholders’ equity
Preferred stock
Common stock 287 219
Additional paid-in capital 548,811 276,042
Accumulated other comprehensive loss (13 )
Accumulated deficit (123,143 ) (75,981 )
Total stockholders’ equity 425,955 200,267
Total liabilities and stockholders’ equity $ 532,111 $ 245,771
Wednesday, February 3rd, 2010 Uncategorized Comments Off on NetLogic Microsystems (NETL) Announces Fourth Quarter 2009 Financial Results

Auxilium (AUXL) Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM)

Feb. 3, 2010 (PR Newswire) — Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren’s Contracture

MALVERN, Pa. — Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, just announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren’s contracture patients with a palpable cord. The Company expects to begin shipping XIAFLEX to its distribution partners in early March in advance of a launch planned for late March.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/auxilium/41254/

“We believe the approval of XIAFLEX represents a major breakthrough for patients suffering from the debilitating effects of Dupuytren’s contracture,” said Armando Anido, Chief Executive Officer and President of Auxilium. “XIAFLEX is the only FDA-approved nonsurgical medical treatment for Dupuytren’s contracture. I want to thank the employees of Auxilium and all of the clinical investigators who worked so hard to make this breakthrough a reality.”

The Company will market and sell XIAFLEX in the United States through a team of approximately 100 field sales managers and representatives, reimbursement specialists and managed market account directors. In addition, a staff of 11 highly trained medical science liaisons will provide medical support for XIAFLEX. The Company has established a distribution network that will allow health care providers to access XIAFLEX through specialty distributors and specialty pharmacies or in the institutional setting after they have undergone training on XIAFLEX and its administration. For information and questions on XIAFLEX, patients and physicians can contact Auxilium at 1-877-XIAFLEX.

“With the safety and effectiveness of XIAFLEX demonstrated across multiple clinical trials, physicians can now use XIAFLEX to treat any symptomatic cords in patients with Dupuytren’s contracture,” said Larry Hurst, M.D., study investigator and Professor and Chair, Department of Orthopaedics at SUNY Stony Brook. “I believe that XIAFLEX, as a new nonsurgical treatment, could potentially become the standard of care for Dupuytren’s contracture.”

FDA has required a risk evaluation and mitigation strategy (REMS) program for XIAFLEX, which consists of a communication plan and a medication guide. This REMS is designed to (1) evaluate and mitigate known and potential risks and serious adverse events; (2) to inform healthcare providers about how to properly inject XIAFLEX and perform finger extension procedures; and, (3) to inform patients about the serious risks associated with XIAFLEX. Auxilium plans to market XIAFLEX to physicians who are experienced in injection procedures of the hand and treatment of Dupuytren’s contracture and will only provide access to XIAFLEX after physicians have attested to completion of a training program. The training program is available as a video or written manual and demonstrates proper use and administration of XIAFLEX, as well as an overview of both identified and potential risks with XIAFLEX.

XIAFLEX’s product insert is available via our website at www.XIAFLEX.com.

XIAFLEX is a prescription medicine used to treat adults with Dupuytren’s contracture when a “cord” can be felt. Over time, the thickening of this cord in your hand can cause one or more fingers to bend toward your palm, so that you cannot straighten them. XIAFLEX should be injected into the cord by a healthcare provider who is experienced in injection procedures of the hand and treating people with Dupuytren’s contracture. XIAFLEX helps “break” the cord that is causing the finger to be bent.

IMPORTANT SAFETY INFORMATION

XIAFLEX can cause serious side effects, including:

  • Tendon or ligament damage. Receiving an injection of XIAFLEX may cause damage to a tendon or ligament in your hand and cause it to break or weaken. This could require surgery to fix the damaged tendon or ligament. Call your healthcare provider right away if you have trouble bending your injected finger (towards the wrist) after the swelling goes down or you have problems using your treated hand after your follow-up visit.
  • Nerve injury or other serious injury of the hand. Call your healthcare provider if you get numbness, tingling, or increased pain in your treated finger or hand after your injection or after your follow-up visit.
  • Allergic Reactions. Allergic reactions can happen in people who have received an injection of XIAFLEX because it contains foreign proteins. Call your healthcare provider right away if you have any of these symptoms of an allergic reaction after an injection of XIAFLEX: hives; swollen face; breathing trouble; or chest pain.

Before receiving XIAFLEX, tell your healthcare provider if you have had an allergic reaction to a previous XIAFLEX injection, or have a bleeding problem or any other medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Be sure to tell them if you use blood thinners such as aspirin, clopidogrel (Plavix®), prasugrel hydrochloride (Effient®), or warfarin sodium (Coumadin®).

Common side effects with XIAFLEX include: swelling of the injection site or the hand, bleeding or bruising at the injection site; and pain or tenderness of the injection site or the hand, swelling of the lymph nodes (glands) in the elbow or underarm, itching, breaks in the skin, redness or warmth of the skin, and pain in the underarm.

Please see Full Prescribing Information and Medication Guide.

Conference Call

Auxilium will hold a conference call February 3 at 8:30 a.m. ET, to discuss the U.S. approval of XIAFLEX for the treatment of Dupuytren’s contracture and other related topics. The conference call will be simultaneously web cast on Auxilium’s web site and archived for future review until March 3, 2010.

    Conference call details:
    Date:                            Wednesday, February 3, 2010
    Time:                            8:30 a.m. ET
    Dial-in (U.S.):                  866-202-1971
    Dial-in (International):         617-213-8842
    Web cast:                        http://www.auxilium.com
    Passcode:                        Auxilium

    To access an audio replay of
     the call:
    Access number (U.S.):            888-286-8010
    Access number (International):   617-801-6888
    Replay Passcode #:               90800506

About Dupuytren’s Contracture

Dupuytren’s contracture is a condition that affects the connective tissue that lies beneath the skin in the palm. The disease is progressive in nature. Typically, skin pits then nodules develop in the palm as collagen deposits accumulate. As the disease progresses, the collagen deposits form a cord that stretches from the palm of the hand to the base of the finger. Once this cord develops, the patient’s fingers contract and the function of the hand is impaired. Currently, surgery is the only effective treatment. The incidence of Dupuytren’s disease, inclusive of pits, nodules and cords, is highest in Caucasians, historically those of Northern European descent, with a global prevalence of three to six percent of the Caucasian population. (1) Most cases of Dupuytren’s contracture occur in patients older than 50 years. (2)

The most frequently affected parts of the hand associated with Dupuytren’s contracture are the joints called the Metacarpal Phalangeal Joint, or MP joint, which is the joint closest to the palm of the hand and the Proximal Intra-Phalangeal Joint, or the PIP joint, which is the middle joint in the finger. The little finger and ring finger are most frequently involved. XIAFLEX is the only drug approved by the U.S. Food and Drug Administration for treatment of Dupuytren’s contracture, which has historically been treated primarily by an open surgical procedure.

(1) Hurst, L. C. et al., Injectable Collagenase Clostridium Histolyticum for Dupuytren’s Contracture, New England Journal of Medicine, (2009; 361:968-979)

(2) Badalamente, M. A., Hurst, L. C. et al., Collagen as a Clinical Target: Nonoperative Treatment of Dupuytren’s Disease, The Journal of Hand Surgery, (2002; 27A:788-798)

About Auxilium

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium will market XIAFLEX™ (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s contracture patients with a palpable cord and markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium has four projects in clinical development. XIAFLEX is in phase IIb of development for the treatment of Peyronie’s disease and is in phase II of development for treatment of Frozen Shoulder syndrome (Adhesive Capsulitis). Auxilium’s transmucosal film product candidate for the treatment of overactive bladder (AA4010) and its fentanyl pain product using its transmucosal delivery system are in phase I of development. The Company is currently seeking a partner to further develop these product candidates. Auxilium has rights to additional pain products and products for hormone replacement and urologic disease using its transmucosal film delivery system. Auxilium also has options to all indications using XIAFLEX for non-topical formulations. For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This release contains “forward-looking-statements” within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the date on which the Company will ship XIAFLEX for the treatment of Dupuytren’s to its distribution partners; the timing of launch of XIAFLEX; the number of field sales managers and representatives, reimbursement specialists and managed market account directors, and medical science liaisons supporting XIAFLEX; the distribution network for XIAFLEX; the design of the risk evaluation and mitigation strategy for XIAFLEX; the access to XIAFLEX by only physicians who are experienced in the injection procedures of the hand and treatment of Dupuytren’s contracture after they had attested to completion of a training program; the number of patients with Dupuytren’s contracture; products in development for Peyronie’s disease, Frozen Shoulder syndrome, overactive bladder, pain, hormone replacement and urologic disease; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as “believe,” “appears,” “may,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium’s Annual Report on Form 10-K for the year ended December 31, 2008, in Auxilium’s Quarterly Report on Form 10-Q for the period ended June 30, 2009 and in Auxilium’s Quarterly Report on Form 10-Q for the period ended September 30, 2009 under the heading “Risk Factors”, which are on file with the Securities and Exchange Commission (the “SEC”) and may be accessed electronically by means of the SEC’s home page on the Internet at http://www.sec.gov or by means of Auxilium’s home page on the Internet at http://www.Auxilium.com under the heading “For Investors — SEC Filings.” There may be additional risks that Auxilium does not presently know or that Auxilium currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium’s expectations, plans or forecasts of future events and views as of the date of this release. Auxilium anticipates that subsequent events and developments will cause Auxilium’s assessments to change. However, while Auxilium may elect to update these forward-looking statements at some point in the future, Auxilium specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Auxilium’s assessments as of any date subsequent to the date of this release.

For More Information:
James E. Fickenscher
Chief Financial Officer
Auxilium Pharmaceuticals, Inc.
1-484-321-5900
jfickenscher@auxilium.com
William Q. Sargent Jr.
Vice-President
Investor Relations and Corporate Communications
1-484-321-5900
wsargent@auxilium.com

SOURCE Auxilium Pharmaceuticals, Inc.

Wednesday, February 3rd, 2010 Uncategorized Comments Off on Auxilium (AUXL) Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM)

Acme Packet (APKT) Reports Record Results for Fourth Quarter of 2009

Feb. 2, 2010 (Business Wire) — Acme Packet, Inc. (NASDAQ:APKT), the leader in session border control solutions, today announced record results for the fourth quarter ended December 31, 2009 and raised its business outlook for 2010.

Results for the Fourth Quarter of 2009

Total revenue for the fourth quarter of 2009 was $41.3 million, compared to $30.6 million in the fourth quarter of last year and $36.3 million in the third quarter of 2009. Net income for the fourth quarter of 2009 was $9.1 million, or $0.14 per share on a diluted basis, compared to $3.7 million, or $0.06 per share on a diluted basis in the fourth quarter of 2008 and $3.6 million, or $0.06 per share on a diluted basis, in the third quarter of 2009. Net income on a non-GAAP basis for the fourth quarter of 2009 was $6.8 million, or $0.11 per share on a diluted basis, compared to $5.6 million, or $0.09 per share on a diluted basis, in the same period last year, and $5.7 million, or $0.09 per share on a diluted basis, in the third quarter of 2009. A reconciliation of GAAP to non-GAAP results is included at the end of this press release.

“We are pleased to report strong fourth quarter results which were highlighted by record revenues and solid earnings growth. Accelerating demand for our solutions over the last year has led to growing momentum in all areas of the business,” said Andy Ory, President and Chief Executive Officer of Acme Packet, Inc. “Looking ahead, we now expect to deliver revenue and earnings growth of approximately 30% in 2010 with operating margin, excluding stock-based compensation and amortization of acquired intangible assets, approaching 30% by the fourth quarter.”

Results for 2009

Total revenue for 2009 was $141.5 million, an increase of 22% compared to $116.4 million in 2008. Net income in 2009 was $17.1 million, or $0.28 per share on a diluted basis, compared to $11.6 million, or $0.18 per share on a diluted basis in 2008. Net income on a non-GAAP basis was $21.3 million, or $0.35 per share on a diluted basis, compared to $17.1 million, or $0.27 per share on a diluted basis in 2008. A reconciliation of GAAP to non-GAAP results is included at the end of this press release.

Company Raises Business Outlook for 2010

The Company today raised its full year business outlook for 2010. The Company’s outlook is based on the current indications for its business, which may change at any time.

Year Ended December 31, 2010
In Millions Except Per Share

Amounts and Tax Rates

PreviousBusiness

Outlook

NewBusiness

Outlook

Total revenue $166-$168 $182-$186
Total revenue growth rate Approximately 20% Approximately 30%
Non-GAAP diluted EPS $0.41-$0.42 $0.44-$0.47
Non-GAAP diluted EPS growth rate Approximately 20% Approximately 30%
Non-GAAP tax rate 34% 37%
Diluted share count 62.0 64.0

Company to Host Live Conference Call and Webcast

The Company’s management team will host a live conference call and webcast at 5:00 p.m. eastern time today to discuss the financial results as well as management’s outlook for the business. The conference call may be accessed in the United States by dialing (800) 230-1074 and using access code “APKT”. The conference call may be accessed outside of the United States by dialing +1 612.234.9960 and using access code “APKT”. The conference call will be simultaneously webcast on the Company’s investor relations website, which can be accessed at www.ir.acmepacket.com. A replay of the conference call will be available approximately two hours after the call by dialing (800) 475-6701 and using access code 140323 or by accessing the webcast replay on the Company’s investor relations website.

1A reconciliation of GAAP to non-GAAP results is included at the end of this press release.

About Acme Packet, Inc.

Acme Packet, Inc. (NASDAQ: APKT), the leader in session border control solutions, enables the delivery of trusted, first-class interactive communications—voice, video and multimedia sessions—and data services across IP network borders. Our Net-Net family of session border controllers, multiservice security gateways and session routing proxies supports multiple applications in service provider, enterprise and contact center networks—from VoIP trunking to hosted enterprise and residential services to fixed-mobile convergence. They satisfy critical security, service assurance and regulatory requirements in wireline, cable and wireless networks; and support multiple protocols—SIP, H.323, MGCP/NCS, H.248 and RTSP—and multiple border points—service provider access and interconnect, and enterprise access and trunking. Our products have been selected by more than 980 customers in 104 countries. They include 47 of the top 50, and 90 of the top 100 service providers in the world; and 11 of the Fortune 25. For more information, contact us at +1 781.328.4400, or visit www.acmepacket.com.

Acme Packet, Inc. Safe Harbor Statement

Statements contained herein that are not historical fact (including those in the section “Company Raises Business Outlook for 2010”) may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may relate, among other things, to expected financial and operating results and to future business prospects and market conditions. Such forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties that could cause actual results to differ materially from those anticipated. These include, but are not limited to: difficulties expanding its customer base; difficulties leveraging market opportunities; difficulties providing solutions that meet the needs of customers; poor product sales; long sales cycles; difficulty developing new products; difficulty in relationships with vendors and partners; difficulties in integrating an acquired business; higher risk in international operations; difficulty managing rapid growth; difficulty managing its financial performance; its ability to hire and retain employees and appropriately staff its operations; the spending of the proceeds of its capital raising activities; its cash needs; and the impact of new accounting pronouncements and increased competition. Additional factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in the Company’s recent filings with the Securities and Exchange Commission, including those factors discussed under the caption “Risk Factors” in such filings.

Acme Packet, Inc.

Condensed Consolidated Statements of Income

(in thousands, except share and per share data)

(unaudited)

Three Months Ended Twelve Months Ended
December 31,

2009

December 31,2008 December 31,

2009

December 31,2008
Revenue:
Product $ 32,124 $ 22,491 $ 107,144 $ 91,277
Maintenance, support and service 9,139 8,090 34,314 25,081
Total revenue 41,263 30,581 141,458 116,358
Cost of revenue (a) (b):
Product 6,333 5,568 21,613 19,662
Maintenance, support and service 1,765 1,266 5,668 5,005
Total cost of revenue 8,098 6,834 27,281 24,667
Gross profit 33,165 23,747 114,177 91,691
Operating expenses (a) (b):
Sales and marketing 15,996 11,276 53,643 44,411
Research and development 7,685 5,595 28,198 23,046
General and administrative 2,631 2,941 12,305 10,026
Merger and integration-related costs 1,102
Total operating expenses 26,312 19,812 95,248 77,483
Income from operations 6,853 3,935 18,929 14,208
Other income, net 25 199 175 2,979
Gain on acquisition of business 4,293 4,293
Income before provision for income taxes 11,171 4,134 23,397 17,187
Provision for income taxes 2,096 450 6,291 5,615
Net income $ 9,075 $ 3,684 $ 17,106 $ 11,572
Net income per share:
Basic $ 0.16 $ 0.07 $ 0.30 $ 0.20
Diluted $ 0.14 $ 0.06 $ 0.28 $ 0.18
Weighted average number of common shares used in net income per share calculation:
Basic 58,423,418 55,171,538 57,077,639 58,463,410
Diluted 63,446,095 58,722,530 61,551,040 62,920,268
(a) Amounts include stock-based compensation expense, as follows:
Cost of product revenue $ 120 $ 111 $ 501 $ 440
Cost of maintenance, support and service revenue 155 107 570 408
Sales and marketing 1,169 954 4,706 3,686
Research and development 902 674 3,439 2,083
General and administrative 294 221 1,142 781
(b) Amounts include amortization of acquired intangible assets, as follows:
Cost of product revenue $ 208 $ 555
Sales and marketing 21 51
Research and development 69 102

Acme Packet, Inc.

Reconciliation of Non-GAAP Net Income and Other Operational Data

(in thousands, except per share data)

(unaudited)

The Company uses the financial measures “non-GAAP net income” and “non-GAAP net income per share” to supplement its consolidated financial statements, which are presented in accordance with accounting principles generally accepted in the United States (“GAAP”). The presentation of non-GAAP net income and non-GAAP net income per share is not meant to be a substitute for “net income” or “net income per share”, presented in accordance with GAAP, but rather should be evaluated in conjunction with net income and net income per share. The Company’s management believes that the presentation of non-GAAP net income and non-GAAP net income per share provides useful information to investors because this financial measure excludes stock-based compensation expense which is a non-cash charge. Non-GAAP net income and non-GAAP net income per share for the three months ended September 30, 2009 and the three and twelve months ended December 31, 2009 also excludes amortization of acquired intangible assets associated with the Company’s acquisition of Covergence Inc. on April 30, 2009. Non-GAAP net income and non-GAAP net income per share for the twelve months ended December 31, 2009 also excludes merger and integration-related costs associated with the Company’s acquisition of Covergence Inc. on April 30, 2009. Non-GAAP net income and non-GAAP net income per share for the three and twelve months ended December 31, 2009 also excludes a gain associated with the Company’s acquisition of Covergence on April 30, 2009. By excluding stock-based compensation expense, amortization of acquired intangible assets, merger and integration-related expenses and the gain associated with the Company’s acquisition of Covergence, management can compare the Company’s ongoing operations to prior periods and to the ongoing operations of other companies in its industry who may have materially different unusual charges. Management does not consider any of stock-based compensation expense, amortization of acquired intangible assets, merger and integration-related expenses and the gain associated with the Company’s acquisition of Covergence to be part of the Company’s ongoing operating activities or meaningful in evaluating the Company’s past financial performance or future prospects. Management believes that excluding these items is useful to investors because it is more representative of ongoing costs and therefore more comparable to historical operations. Non-GAAP net income and non-GAAP net income per share are primary financial indicators that the Company’s management uses to evaluate the Company’s financial results and forecast anticipated financial results for future periods. Management also uses these non-GAAP figures to make financial and operational decisions as these numbers exclude non-operational activities. These non-GAAP measures should not be considered measures of the Company’s liquidity. The Company’s definition of “non-GAAP net income” and/or “non-GAAP net income per share” may differ from similar measures used by other companies and may differ from period to period. Subject to the review and approval of the audit committee of the Board of Directors, management may make other adjustments for expenses and gains that it does not consider reflective of core operating performance in a particular period and may modify “non-GAAP net income” and/or “non-GAAP net income per share” by excluding these expenses and gains.

Three Months Ended Twelve Months Ended
December 31,

2009

September 30,

2009

December 31,

2008

December 31,

2009

December 31,

2008

Reconciliation of non-GAAP net income:
Net income $ 9,075 $ 3,580 $ 3,684 $ 17,106 $ 11,572
Adjustments:
Stock-based compensation expense, net of taxes 1,824 1,923 1,879 7,137 5,482
Amortization of acquired intangible assets 194 164 461
Merger and integration-related costs, net of taxes 903
Gain on acquisition of business (4,293 ) (4,293 )
Non-GAAP net income $ 6,800 $ 5,667 $ 5,563 $ 21,314 $ 17,054
Reconciliation of non-GAAP net income per share:
Net income per share, Basic $ 0.16 $ 0.06 $ 0.07 $ 0.30 $ 0.20
Adjustments:
Stock-based compensation expense, net of taxes 0.03 0.04 0.03 0.12 0.09
Amortization of acquired intangible assets 0.01
Merger and integration-related costs, net of taxes 0.02
Gain on acquisition of business (0.07 ) (0.08 )
Non-GAAP net income per share, Basic $ 0.12 $ 0.10 $ 0.10 $ 0.37 $ 0.29
Net income per share, Diluted $ 0.14 $ 0.06 $ 0.06 $ 0.28 $ 0.18
Adjustments:
Stock-based compensation expense, net of taxes 0.03 0.03 0.03 0.12 0.09
Amortization of acquired intangible assets 0.01
Merger and integration-related costs, net of taxes 0.01
Gain on acquisition of business (0.06 ) (0.07 )
Non-GAAP net income per share, Diluted $ 0.11 $ 0.09 $ 0.09 $ 0.35 $ 0.27
Other operational data:
Depreciation and amortization $ 1,590 $ 1,529 $ 1,786 $ 5,379 $ 5,900
Capital expenditures $ 1,082 $ 1,449 $ 827 $ 4,868 $ 4,042
Acme Packet, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

December 31,2009 December 31,

2008

Assets
Current assets:
Cash and cash equivalents $ 90,471 $ 125,723
Short-term investments 39,990
Accounts receivable, net 25,604 26,163
Inventory 4,372 5,884
Deferred product cost of revenue 3,400 1,124
Deferred tax asset 1,567 1,262
Other current assets 2,710 1,362
Total current assets 168,114 161,518
Long-term investments 44,526
Property and equipment, net 6,437 5,485
Intangible assets, net 11,228
Deferred tax asset, net 15,622 6,540
Other assets 799 467
Total assets $ 246,726 $ 174,010
December 31,

2009

December 31,

2008

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 3,895 $ 3,364
Accrued expenses and other current liabilities 9,261 6,865
Deferred revenue 31,506 15,283
Total current liabilities 44,662 25,512
Deferred rent 96
Deferred revenue 1,841 1,591
Stockholders’ equity:
Common stock 65 61
Treasury stock, at cost (37,522 ) (37,522 )
Additional paid-in capital 188,871 152,567
Other comprehensive loss (2 )
Retained earnings 48,811 31,705
Total stockholders’ equity 200,223 146,811
Total liabilities and stockholders’ equity $ 246,726 $ 174,010
Condensed Consolidated Statements of Cash Flow

(in thousands)

(unaudited)

Three Months Ended Twelve Months Ended
December 31,

2009

December 31,2008 December 31,

2009

December 31,2008
Cash provided by operating activities $ 15,924 $ 7,045 $ 45,263 $ 28,671
Cash used in investing activities (86,349 ) (827 ) (84,275 ) (4,042 )
Cash provided by (used in) financing activities 2,095 (7,532 ) 3,760 (35,326 )

Wednesday, February 3rd, 2010 Uncategorized Comments Off on Acme Packet (APKT) Reports Record Results for Fourth Quarter of 2009

Home Diagnostics, Inc. (HDIX) Agrees to Be Acquired by Nipro Corporation

Feb. 3, 2010 (Business Wire) — Home Diagnostics, Inc. (NASDAQ: HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million). The offer price represents an approximately 90% premium to the closing price of Home Diagnostics’ common stock on February 2, 2010, and an approximately 83% premium to Home Diagnostics’ average closing price for the preceding 90 days.

The two-step acquisition will be effected by means of a first-step, cash tender offer commenced by a wholly-owned subsidiary of Nipro for all of the outstanding shares of Home Diagnostics’ common stock, at $11.50 net per share in cash, followed by a second-step merger in which untendered Home Diagnostics’ shares will be acquired at the same $ 11.50 net cash price per share. All Home Diagnostics’ stock options and stock appreciation rights will receive cash equal to the excess, if any, of $11.50 over their exercise price.

The transaction has been approved by Nipro and the board of directors of Home Diagnostics. The tender offer, which will remain open for a minimum of 20 business days, subject to certain extensions as required by applicable law and the terms of the merger agreement, is subject to certain conditions, including the valid tender and acceptance for payment in the tender offer of a majority of the fully diluted Home Diagnostics common stock, the expiration or early termination of the applicable waiting period under the Hart-Scott-Rodino Act, and other customary conditions. The tender offer is not subject to a financing condition.

Certain stockholders of Home Diagnostics, owning in the aggregate approximately 15% of Home Diagnostics’ outstanding common stock, have committed to tender their shares in the offer. Home Diagnostics has also granted Nipro a “top-up” option exercisable under certain circumstances to enable Nipro to own 90% of the fully diluted Home Diagnostics common stock and complete the second step of its acquisition of Home Diagnostics by means of a “short form” merger not requiring approval by Home Diagnostics’ stockholders. Nipro has also reserved the right to commence a “subsequent offering period” following the expiration of the initial tender offer period if Nipro then owns less than 90% of the fully diluted Home Diagnostics common stock.

The merger agreement permits Home Diagnostics’ board, under certain circumstances prior to the completion of the Offer, to enter into discussions and negotiations and furnish information to third parties who submit to Home Diagnostics unsolicited acquisition proposals which Home Diagnostics’ board of directors determines to be reasonably likely to lead to a superior offer and, thereafter, to terminate the transaction with Nipro and enter into a definitive agreement providing for a superior offer, subject to Nipro’s right to match or improve the terms of any such superior offer and further subject to the payment to Nipro of a $6,500,000 termination fee or reimbursement of certain of Nipro’s out of pocket expenses in other circumstances.

Joseph Capper, President and CEO of Home Diagnostics, said, “First and foremost, we are pleased to announce this transaction which provides a substantial current cash premium to our stockholders. We believe this transaction is also beneficial to our customers and suppliers because it greatly enhances Home Diagnostics’ capabilities by expanding our product offering and aligning our business with a global healthcare company.”

The parties expect the tender offer to commence on or about February 10, 2010. The tender offer will remain open for 20 business days from commencement, subject to extension under certain circumstances as required by applicable law and the terms of the merger agreement. Subject to the satisfaction of the conditions to the tender offer, the offer is expected to be consummated prior to the end of the first quarter of 2010.

With respect to the transactions, Raymond James Financial, Inc. is acting as financial advisor to Home Diagnostics; Satterlee Stephens Burke & Burke LLP is acting as legal advisor to Home Diagnostics; and Greenberg Traurig, LLP is acting as special M&A counsel to Home Diagnostics. Baker & McKenzie LLP is acting as legal advisor to Nipro Corporation.

About Home Diagnostics

Based in Fort Lauderdale, Florida, Home Diagnostics (NASDAQ: HDIX) is a leading developer, manufacturer and marketer of diabetes management products. Home Diagnostics offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics product line includes TRUE2go™, TRUEresult®, TRUEtrack®, TRUEbalance™, Sidekick®, TRUEread® and Prestige IQ® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring systems for leading pharmacies including CVS, Rite Aid and Walgreens, as well as distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. Home Diagnostics was named one of Forbes magazine’s “200 Best Small Companies” in 2008, and in 2009 received several recognitions for the company’s TRUE2go blood glucose meter, including a Medical Design Excellence Award (MDEA) and a Gold Award in the Medical/Test Equipment category as part of appliance DESIGN Magazine’s 22nd Annual Excellence in Design (EID) Awards Competition. For more information please visit www.homediagnostics.com.

About Nipro Corporation

Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), founded in 1954, is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-relates products. Nipro’s pharmaceutical division is engaged in the research, manufacture and sale of pharmaceuticals, such as blood derivatives. The instrument division of Nipro manufactures and sells glass pipes and other glass products, including the inner bottles of thermos bottles. Nipro and its subsidiaries also sell medical device manufacturing equipment and conduct real estate leasing and non-life insurance agency businesses. For more information please visit www.nipro.co.jp.

Important information

The tender offer described in this press release has not yet commenced. This announcement and the description contained herein is neither an offer to purchase nor a solicitation of an offer to sell shares of Home Diagnostics. At the time the tender offer is commenced, Nipro and its wholly-owned subsidiary intend to file with the Securities and Exchange Commission a Tender Offer Statement on Schedule TO containing an offer to purchase, forms of letters of transmittal and other documents relating to the tender offer, and Home Diagnostics intends to file with the SEC a Solicitation/Recommendation Statement on Schedule 14D−9 with respect to the tender offer. Nipro, its wholly-owned subsidiary and Home Diagnostics intend to mail these documents to the stockholders of Home Diagnostics. These documents will contain important information about the tender offer and stockholders of Home Diagnostics should read them carefully when they become available before any decision is made with respect to the tender offer. Stockholders of Home Diagnostics will be able to obtain a free copy of these documents (when they become available) and other documents filed by Home Diagnostics with the SEC at the website maintained by the SEC at www.sec.gov. In addition, stockholders of Home Diagnostics will be able to obtain a free copy of these documents (when they become available) from Home Diagnostics by contacting Home Diagnostics, Inc. at 2400 N.W. 55th Court, Ft. Lauderdale, FL 33309, attention Peter Ferola, General Counsel.

None of the information included on any internet website maintained by Nipro Corporation, Home Diagnostics or any of their affiliates, or any other internet website linked to any such website, is incorporated by reference or otherwise made a part of in this press release

Forward-looking statements

The statements made in this press release which are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. As a result of a number of factors, our actual results could differ materially from those set forth in the forward-looking statements. Certain factors that might cause our actual results to differ materially from those in the forward-looking statements include, without limitation: (i) the risk that the conditions to the closing of the tender offer or the merger set forth in the merger agreement will not be satisfied, (ii) changes in Home Diagnostics’ business during the period between the date of this press release and the closing, including possible disruption from the transaction making it more difficult for Home Diagnostics to maintain relationships with its customers, suppliers, employees, other business partners or governmental entities, (iii) obtaining regulatory approvals (if required) for the transaction, (iv) the risk that the transaction will not be consummated on the terms or timeline first announced, and (v) those factors set forth under the heading “Risk Factors” in our annual report on Form 10−K for the year ended December 31, 2008. The forward-looking statements are made only as of the date of press release. Except as otherwise required by law, Nipro and Home Diagnostics each specifically disclaim any obligation to update any of these forward looking statements.

TRUE2go, TRUEresult, TRUEbalance, TRUEtrack, Sidekick, TRUEread, Prestige IQ, TRUEfill and TRUEtest are trademarks of Home Diagnostics. All other trademarks are property of their respective owners.

Wednesday, February 3rd, 2010 Uncategorized Comments Off on Home Diagnostics, Inc. (HDIX) Agrees to Be Acquired by Nipro Corporation

Micronetics (NOIZ) Reports Third Quarter Results for Fiscal Year 2010

Press Release Source: Micronetics, Inc. On Tuesday February 2, 2010, 6:30 am EST

HUDSON, N.H.–(BUSINESS WIRE)–Micronetics, Inc. (NASDAQ:NOIZNews) today reported results for its thirteen and thirty-nine weeks ended December 26, 2009.

Net sales for the third quarter (Q3 FY2010) were $9.0 million, an increase of 7% or $.6 million compared to $8.4 million for Q3 FY2009. The increase in net sales for Q3 FY2010 is primarily due to integrated component sub-systems. Sales of components were approximately equal to last year with increases in high power amplifiers and an existing space based contract offset by declines in other components.

For Q3 FY2010 the Company reported net income of $504,143 or $0.11 per diluted share, as compared to a net loss of $9.4 million or $1.96 per diluted share for Q3 FY2009. The net loss for Q3 FY2009 was primarily attributable to a non-cash goodwill and intangible asset impairment charge of $9.3 million.

Net sales for the thirty-nine weeks ended December 26, 2009 were $25.7 million, an increase of 17% or $3.7 million compared to $22.0 million for the thirty-nine weeks ended December 27, 2008. The increase in net sales is primarily attributable to an increase in sales of integrated component sub-systems for jamming and electronic modernization of approximately $2.1 million, an RFID beta test product sale of $.7 million and sales related to a space based contract of $1.0 million.

For the thirty-nine weeks ended December 26, 2009, the Company reported net income of $678,401 or $0.15 per diluted share, as compared to a net loss of $9.3 million or $1.88 per diluted share for the thirty-nine weeks ended December 27, 2008.

Backlog increased to approximately $32 million on $10 million in bookings for the quarter.

David Robbins, Micronetics’ CEO stated, “We are pleased with our third quarter performance. Our optimistic outlook is driven by continued strong defense bookings and some positive signs of recovery in the commercial market coupled with our demonstrated ability to convert backlog into profitable revenue.”

Micronetics manufactures microwave and radio frequency (RF) components and integrated subassemblies used in a variety of defense, aerospace and commercial applications. Micronetics also manufactures and designs test equipment and components that test the strength, durability and integrity of communication signals in communications equipment. Micronetics serves a diverse customer base, including AeroSat, Anritsu, BAE Systems, Boeing Company, General Dynamics, ITT Electronic Warfare Systems, L-3 Communications, Northrop Grumman, Raytheon, and Thales. In addition, direct government customers including DFAS, Hill AFB, Augusta Aerospace and NAVICP. Additional information can be found on our website at http://www.micronetics.com.

Some of the statements contained in this news release are forward-looking statements. The accuracy of these statements cannot be guaranteed as they are subject to a variety of risks, including but not limited to changes in economic conditions, reductions in spending by certain of our customers, our ability to operate and integrate acquired businesses and products, our ability to manage our growth, disruptions in supply or production, increased levels of debt, our ability to protect our proprietary information, future economic conditions in our industry and generally, as well as other factors. The information in this release should be reviewed in conjunction with Micronetics’ Annual Report for its fiscal year ended March 31, 2009 as well as its other filings with the Securities and Exchange Commission.

INCOME STATEMENT DATA
($000s omitted except per share data)
Thirteen Weeks Ended
Dec. 26, 2009 Dec. 27, 2008
Net sales $ 9,009 $8,398
Gross profit 3,307 2,746
Research and development 411 484
Selling, general and
administrative expenses
1,878 1,956
Goodwill impairment charge 7,965
Intangible asset impairment charge 1,295
Amortization of intangibles 87 161
Other expense 96 197
Income (loss) before income taxes 835 (9,312 )
Provision for income taxes 331 72
Net income (loss) 504 (9,384 )
Net income (loss) per common share:
Basic $ 0.11 $ (1.96 )
Diluted $ 0.11 $ (1.96 )
Weighted average shares
Outstanding:
Basic 4,554 4,788
Diluted 4,554 4,788
INCOME STATEMENT DATA
($000s omitted except per share data)
Thirty Nine Weeks Ended
Dec. 26, 2009 Dec. 27, 2008
Net sales $ 25,742 $22,030
Gross profit 8,665 7,793
Research and development 1,257 1,214
Selling, general and
administrative expenses
5,714 5,862
Goodwill impairment charge 7,965
Intangible asset impairment charge 1,295
Amortization of intangibles 261 499
Other expense 295 234
Income (loss) before income taxes 1,138 (9,276 )
Provision for income taxes 460 17
Net income (loss) 678 (9,293 )
Net income per common share:
Basic $ 0.15 $ (1.88 )
Diluted $ 0.15 $ (1.88 )
Weighted average shares
Outstanding:
Basic 4,554 4,934
Diluted 4,554 4,934

Tuesday, February 2nd, 2010 Uncategorized Comments Off on Micronetics (NOIZ) Reports Third Quarter Results for Fiscal Year 2010

Compugen (CGEN) Discovers Novel Protein for Treatment of Autoimmune Diseases

Press Release Source: Compugen Ltd. On Tuesday February 2, 2010, 7:00 am EST

TEL AVIV, Israel–(BUSINESS WIRE)–Compugen Ltd. (NASDAQ: CGENNews) announced today the discovery and experimental validation of CGEN-15001 for the treatment of autoimmune disorders. CGEN-15001 is the extracellular region of a previously unknown membrane protein in the B7/CD28 family. The existence and potential utility of the newly discovered parent protein from which CGEN-15001 is derived was predicted in silico utilizing Compugen’s LEADS Platform and other proprietary algorithms.

Autoimmune diseases develop when defects in the immune system lead the body to attack its own cells, tissues, and organs and include more than 80 chronic, and often disabling, illnesses. Among the most common autoimmune diseases are rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, inflammatory bowel disease, and type 1 diabetes. Collectively, autoimmune diseases are among the most prevalent diseases, affecting an estimated 25 million people in the U.S.

CGEN-15001 is a novel soluble recombinant fusion protein corresponding to the extracellular region of the Compugen discovered parent protein. The discovery of the parent protein, which is a membrane protein, was accomplished through the incorporation in Compugen’s LEADS Platform of additional algorithms specifically designed to predict novel members of the B7/CD28 family of co-stimulatory proteins. This approach relied on Compugen’s proprietary understandings and modeling of genomic structure, gene expression, protein structural domains, and cellular localization. Compugen has filed for patent coverage on both the parent protein, which potentially has other medical uses such as a target for antibody therapeutics, and CGEN-15001.

The in vivo validation of CGEN-15001 utilized a mouse model of multiple sclerosis, relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE). In this model, administration of CGEN-15001 resulted in potent amelioration of the disease state. These results indicate that CGEN-15001 could have therapeutic utility for the treatment of multiple sclerosis and other autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and type 1 diabetes. Earlier in vitro studies validated the predicted functional activity of CGEN-15001 as a new member of the B7/CD28 family proteins.

Professor Stephen Miller from Northwestern University, a leading scientist in this field who supervised the studies, stated, “Our studies have indicated robust disease suppressing activity for CGEN-15001 in the SJL R-EAE model, a recognized mouse model for multiple sclerosis. These studies have also demonstrated that CGEN-15001 has the unique ability to inhibit proliferation, differentiation, and cytokine production of pro-inflammatory Th1 and Th17 responses while at the same time sparing or actually promoting regulatory Th2-derived cytokines. As far as I am aware, this potentially very beneficial pattern of inhibiting Th1/Th17 while promoting Th2 responses is unique among the reagents targeting the B7 family of co-stimulatory molecules that have been published to date.”

Compugen’s VP R&D, Dr. Zurit Levine stated, “We are extremely pleased by this further demonstration of the unique discovery capability that has been created at Compugen. In view of its recognized potential in the largely unmet and critical field of immune regulation, the B7/CD28 co-stimulation protein family has been an area of extensive research for a number of years. In our opinion, in addition to providing Compugen with a very attractive product candidate, the predictive discovery and experimental validation of a previously unknown member of this extensively researched protein family represents a major milestone in the transition from experimentally based therapeutic discovery to in silico prediction and selection.”

About the B7/CD28 protein family

Members of the B7/CD28 family have been intensively studied over the past decade and have brought much excitement to the field of immune regulation. The activation and development of an adaptive immune response is initiated by the engagement of a T-cell antigen receptor by an antigenic peptide-MHC complex. The outcome of this engagement is determined by both positive and negative co-stimulatory signals, generated mainly by the interaction between the B7 family and their receptor CD28 family. A growing body of evidence indicates that the dysfunction of immune regulation contributes to the development of autoimmune diseases. Positive and negative co-stimulatory pathways play critical roles in immune regulation and are considered potential targets for modulating chronic inflammation in autoimmune diseases. To date, one soluble recombinant fusion protein, that selectively blocks the co-stimulatory signal mediated by the B7/CD28 pathway, has been cleared for marketing in the U.S. for the treatment of moderate to severe rheumatoid arthritis, and is in clinical trials for other autoimmune indications. In addition, a number of clinical and preclinical studies of this protein family are underway at various companies.

About LEADS

The LEADS platform provides a comprehensive predictive view of the human transcriptome, proteome and peptidome, and serves as a rich infrastructure for the discovery of novel genes, transcripts and proteins. It includes extensive gene information and annotation, such as splice variants, antisense genes, SNPs, novel genes and RNA editing. At the protein level, LEADS provides full protein annotation, including homologies, domain information, subcellular localization, peptide prediction and novelty status.

About Compugen

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based on in silico (by computer) prediction and selection utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. Compugen’s growing number of collaborations with major pharmaceutical and diagnostic companies cover both (i) the licensing of product candidates discovered by Compugen during the validation of its discovery platforms and in its internal research, and (ii) “discovery on demand” agreements where existing or new Compugen discovery platforms are utilized to predict and select product candidates as required by our partner. In 2002, Compugen established an affiliate, Evogene Ltd. (www.evogene.com) (TASE: EVGN.TA), to utilize certain of the Company’s in silico predictive discovery capabilities in agricultural biotechnology. For additional information, please visit Compugen’s corporate website at www.cgen.com.

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include words such as “may”, “expects”, “anticipates”, “believes”, and “intends”, and describe opinions about future events. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Compugen to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Some of these risks are: changes in relationships with collaborators; the impact of competitive products and technological changes; risks relating to the development of new products; and the ability to implement technological improvements. These and other factors are identified and more fully explained under the heading “Risk Factors” in Compugen’s annual reports filed with the Securities and Exchange Commission.

Tuesday, February 2nd, 2010 Uncategorized Comments Off on Compugen (CGEN) Discovers Novel Protein for Treatment of Autoimmune Diseases

Focus Media (FMCN) Announces US$200 Million Share Repurchase Program

Press Release Source: Focus Media Holding Limited On Tuesday February 2, 2010, 7:19 am EST

SHANGHAI, Feb. 2 /PRNewswire-Asia/ — Focus Media Holding Limited (Nasdaq: FMCN), China’s leading multi-platform digital media company, today announced that its board of directors has approved a share repurchase program. Under the terms of the approved program, Focus Media may repurchase up to US$200 million worth of its issued and outstanding American depositary shares (“ADSs”). The repurchases will be made from time to time on the open market at prevailing market prices or in block trades. The purchases will be made subject to restrictions relating to volume, price and timing. The timing and extent of any purchases will depend upon market conditions, the trading price of its ADSs and other factors. Focus Media expects to implement this share repurchase program over the course of the next 12 months, effective immediately, in a manner consistent with market conditions and the interest of the shareholders and in compliance with the company’s securities trading policy. Focus Media’s board of directors will review the share repurchase program periodically, and may authorize adjustment of its terms and size accordingly. Focus Media plans to fund repurchases made under this program from its available cash balance.

Kit Low, chief financial officer of Focus Media, commented, “Our Board’s approval of the share repurchase program reflects our commitment to increase shareholder value and our confidence that the current ADS price level does not reflect our potential value.”

SAFE HARBOR: FORWARD-LOOKING STATEMENTS

This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Focus Media may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission on forms 20-F and 6-K., in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Focus Media’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, risks outlined in Focus Media’s filings with the U.S. Securities and Exchange Commission, including its registration statements on Form F-1, F-3 and 20-F, in each case as amended. Focus Media does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

This release is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer or selling security holder and that will contain detailed information about the company and management, as well as financial statements.

ABOUT FOCUS MEDIA HOLDING LIMITED

Focus Media Holding Limited (Nasdaq: FMCN) is China’s leading multi- platform digital media company, operating the largest out-of-home advertising network in China using audiovisual digital displays, based on the number of locations and number of flat-panel television displays in our network. Through Focus Media’s multi-platform digital advertising network, the company reaches urban consumers at strategic locations and point-of-interests over a number of media formats, including audiovisual television displays in buildings and stores, advertising poster frames and other new and innovative media, such as outdoor light-emitting diode or LED digital billboard and Internet advertising platforms. As of September 30, 2009, Focus Media’s digital out-of-home advertising network had approximately 125,000 LCD display in its LCD display network and approximately 262,000 advertising in-elevator poster and digital frames, installed in over 90 cities throughout China, and approximately 130 outdoor LED billboard displays in Shanghai and Beijing. For more information about Focus Media, please visit our website at http://ir.focusmedia.cn .

Tuesday, February 2nd, 2010 Uncategorized Comments Off on Focus Media (FMCN) Announces US$200 Million Share Repurchase Program

STAAR Surgical’s (STAA) Visian(R) ICL(TM) is First Phakic Lens to Be Approved in Japan

Press Release Source: STAAR Surgical Company On Tuesday February 2, 2010, 8:00 am EST

MONROVIA, Calif., Feb. 2 /PRNewswire-FirstCall/ — STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the Company’s Visian Implantable Collamer® Lens (ICL) in Japan.

Japan‘s MHLW approved marketing the Visian ICL for the treatment of myopia. The Japanese population is believed to suffer one of the highest rates of myopia in the world, with a much higher percentage of the population in the high myopic range than the worldwide norm. Market Scope, the industry leading ophthalmic research firm, reports that the worldwide average prevalence of myopia is 23% of the population, while the prevalence in Japan is 45%. This compares to an estimated 27% prevalence of myopia in the U.S.  Over 150,000 Visian ICLs have been implanted worldwide since its introduction.

“Today’s announcement represents the achievement of a major milestone for STAAR, and presents us with an opportunity to pursue a very attractive market for the Visian ICL,” said Barry G. Caldwell, President and CEO of STAAR Surgical.  “The Tajimi Study, which evaluated the prevalence of myopia in Japan, reported that the prevalence of myopia was much higher in Japan than in most other parts of the world.  Japan is currently the third largest refractive market and offers an opportunity for additional growth.  This also represents the first approval of the Collamer lens material in Japan and hopefully this can lead to future Collamer lens approvals.”

“We are very excited to introduce the Visian ICL technology in Japan,” added David Bailey, President of International Operations.  “Our organization has been working with the regulatory agencies for several years, and this marks the first Phakic lens approval for the Japanese market.  With the Visian ICL approval, our team at STAAR Japan is swiftly executing our controlled launch plan to maximize both surgeon adoption and patient satisfaction, and we currently expect to hold our first ICL Certification Course at the end of March and begin generating revenue from the product line during the first half of 2010.”

“The Visian ICL is a posterior phakic IOL and has the value not only in safeness due to reversible character, but also in superior visual performance after surgery,” said Dr. Kimiya Shimizu, Professor and Chairman of the Department of Ophthalmology at Kitasato University.  “Because Visian ICL can be less affected by the healing reaction of the corneal wound which differs in patients, it shows better stability and prediction accuracy compared to LASIK.  No expensive laser equipment is necessary and the surgical procedure is easy for experienced cataract surgeons.  Among different methods of vision correction, the Visian ICL is the best method theoretically and this product expands its application not only to high myopia but also to medium myopia.  This is a new encouraging choice for refractive surgery and I assume that this will be popular widely in the Japanese market.”

Having achieved ICL approval, STAAR now intends to file a partial change application for approval of the Visian Toric ICL approval in Japan as soon as practicable following discussions with the Pharmaceuticals and Medical Device Agency(PMDA).  MHLW generally requires up to one year to fully process a partial change application, although that timeline can change based on the nature of the product under review.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma.  Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer® is the brand name for STAAR’s proprietary collagen copolymer lens material. More information is available at www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following:  estimates of future sales of any product, including the ICL in Japan, or any other financial items; the plans, prospects for approval of the Toric ICL in Japan or other actions by regulators, the strategies and objectives of management for future operations or prospects for achieving such plans; our future performance; statements of belief; and any statements of assumptions underlying any of the foregoing.

These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include our limited capital resources and limited access to financing, the fact that our public accounting firm has expressed doubt about our ability to continue as a going concern in their opinion on our financial statements, the cost of satisfying the recent adverse judgment, for which we have taken no reserve, the effect the global recession in reducing sales of products, especially products such as the ICL used in non-reimbursed elective procedures, the challenge of managing our foreign subsidiaries, the willingness of surgeons and patients to adopt a new product and procedure, and the potential effect of recent negative publicity about LASIK on the demand for refractive surgery in general.  Our potential market in Japan may be limited by a number of factors, including the delay in approval of the Toric ICL to treat patients suffering from both astigmatism and myopia.  STAAR assumes no obligation to update its forward-looking statements to reflect future events or actual outcomes and does not intend to do so.

Tuesday, February 2nd, 2010 Uncategorized Comments Off on STAAR Surgical’s (STAA) Visian(R) ICL(TM) is First Phakic Lens to Be Approved in Japan

AXT, Inc. (AXTI) Announces 5-year Contract for Germanium Substrate With AZUR SPACE

Press Release Source: AXT, Inc. On Tuesday February 2, 2010, 9:00 am EST

FREMONT, CA–(Marketwire – 02/02/10) – AXT, Inc. (NASDAQ:AXTINews), a leading manufacturer of compound semiconductor substrates, today announced that it has been awarded a 5-year contract for germanium (Ge) substrates with AZUR SPACE Solar Power GmbH, a leading provider of satellite solar cells for space and terrestrial applications. This contract is the result of a collaboration of the two companies that has enabled AZUR SPACE to obtain an industry-leading 40 percent conversion efficiency rate in average for Triple Junction CPV solar cells and the 30 percent conversion efficiency rate in average for Triple Junction GaAs space solar cells.

“We are very pleased to announce our successful partnership with AZUR SPACE,” said Morris Young, chief executive officer of AXT, Inc. “Since 1964, AZUR SPACE has been at the forefront of the development of solar technology and we are excited that our collaboration over the past months has resulted in one of the highest conversion efficiency rates in the industry, further advancing the potential of this important Triple Junction CPV technology. We are thrilled to be working with them and look forward to a long and prosperous relationship.”

“AXT has been a great partner to work with throughout the qualification process,” said Patrick Kilper, Manager Supply Management of AZUR SPACE. “Its germanium substrates consistently met our stringent requirements and we are pleased that the company has its own source of germanium raw materials to ensure adequate supply as customer demand for our solar cells continues to rise.”

Germanium is a single-element substrate used to produce devices for photovoltaic applications. The material is becoming more widely used for space and terrestrial solar cell applications as the worldwide focus on satellite technology and alternative energy development increases. Europe continues to lead the rest of the world in investment into solar energy development, but government subsidies in the United States, Asia and Australia are promoting the development of this technology around the world.

AXT is a leading supplier of germanium substrates and uniquely has its own source of germanium raw material through its China joint venture.

About AXT, Inc.

AXT designs, develops, manufactures and distributes high-performance compound and single element semiconductor substrates comprising gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge) through its manufacturing facilities in Beijing, China. In addition, AXT maintains its sales, administration and customer service functions at its headquarters in Fremont, California. The company’s substrate products are used primarily in lighting display applications, wireless communications, and fiber optic communications. Its vertical gradient freeze (VGF) technique for manufacturing semiconductor substrates provides significant benefits over other methods and enabled AXT to become a leading manufacturer of such substrates, particularly in optoelectronics applications. AXT has manufacturing facilities in China and invests in five joint ventures producing raw materials. For more information, see AXT’s website at http://www.axt.com.

About AZUR SPACE Solar Power GmbH

AZUR SPACE Solar Power GmbH, with its headquarters in Heilbronn, Germany, develops, produces and supplies bare solar cells for space and terrestrial applications. The company draws from more than 40 years of experience and several million solar cells. Its range of products covers various types of silicon and III-V solar cells on germanium for space application and concentrator photovoltaic systems.

Safe Harbor Statement

The foregoing paragraphs contain forward-looking statements within the meaning of the Federal Securities laws, including statements regarding our qualification of substrates with AZUR SPACE Solar Power GmbH, our commencement of volume orders with AZUR SPACE, and the development of a relationship with AZUR SPACE, our ability to supply raw materials from our own source of germanium raw materials to ensure adequate supply, the rise in customer demand for our solar cells, the increasing use of germanium for satellite and terrestrial solar cell applications, the increasing focus on satellite technology and alternative energy development and government promotion of the development of this technology, and opportunities for growth in the coming years. These forward-looking statements are based upon specific assumptions that are subject to uncertainties and factors relating to the company’s operations and business environment, which could cause actual results of the company to differ materially from those expressed or implied in the forward-looking statements contained in the foregoing discussion. These uncertainties and factors include but are not limited to overall conditions in the markets in which the company competes; market acceptance and demand for the company’s products; and other factors as set forth in the company’s annual report on Form 10-K and other filings made with the Securities and Exchange Commission. Each of these factors is difficult to predict and many are beyond the company’s control. The company does not undertake any obligation to update publicly any forward-looking statement, as a result of new information, future events or otherwise.

Tuesday, February 2nd, 2010 Uncategorized Comments Off on AXT, Inc. (AXTI) Announces 5-year Contract for Germanium Substrate With AZUR SPACE

AuEx Ventures, Inc. (XAU) Final 2009 Long Canyon Holes Produce Strong Results

VANCOUVER, BRITISH COLUMBIA, Feb. 1, 2010 (Marketwire) — AuEx Ventures, Inc. (TSX:XAU) (“AuEx” or the “Company”) is pleased to report assay results for the remaining holes completed as part of the 2009 drilling program at the Company’s 49% owned Long Canyon gold exploration project located within the Pequop Gold District in Elko County, Nevada. These holes include hole LCM22 with 130 feet grading 0.145 ounces per ton (opt), hole LCM30 with 255 feet grading 0.115 opt, hole LCM33 with 140 feet grading 0.096 opt and hole LCM36 with 39 feet grading 0.494 opt. These new intercepts were obtained from core holes drilled as infill holes to confirm and upgrade mineralization and to gather additional material for further metallurgical testing. Essentially all of these holes encountered reportable grade, oxide gold mineralization (see attached table and map). Fronteer Development Group, Inc. (“Fronteer”), operator and 51% owner, provided these results to the Company from the remaining holes completed as part of the 2009 drilling campaign (to see attached map please click on: http://media3.marketwire.com/docs/xau21.jpg). These new results, combined with the results from the holes drilled earlier in 2009, provide a strong confirmation and growing confidence in the geological model and the 3-dimensional distribution of gold within the Long Canyon gold deposit. This knowledge will be of great value in planning further drilling at Long Canyon especially additional step-out drilling to both the northeast and southwest. In addition, these data will benefit the development and testing of new exploration areas on the large 12,000 acre property. This news release is the final announcement of results from all drill holes completed in 2009 at Long Canyon. A total of 238 holes were drilled at Long Canyon during 2009 aggregating 108,766 feet. This included 186 core holes totaling 74,021 feet and 52 reverse circulation drill holes totaling 34,745 feet. The 2010 drilling program is expected to begin in March or April depending on field conditions.

The Long Canyon gold deposit consists of multiple, sub-parallel north to northeast-directed zones of oxidized Carlin-style gold mineralization aggregating 1,300 feet (400 meters) in width with a current strike length of approximately 1.60 miles (2.6 km) that is still open to extension. Mineralization outcrops in the central portion of the deposit, plunges shallowly to the northeast and is amenable to open pit mining. Metallurgical tests completed to date indicate that mineralization is treatable using conventional gold recovery techniques. In addition, significant untested exploration potential is still apparent within the property based on geological mapping and surface geochemical sampling conducted as part of the 2009 exploration program. Other gold exploration targets will be explored as permitting and budgets allow.

Other activity at Long Canyon currently underway includes continuing metallurgical evaluation of column test results on core recovered early in the 2009 program and planning for additional column work utilizing core recovered later in the year and the subject of this press release. In addition, an update to the Long Canyon resource estimate is currently underway and is currently forecasted to be completed during the first half of 2010. This update will incorporate all data from the 2009 drilling campaign. The 2010 budget for Long Canyon is presently under review and will be announced shortly.

As reported to AuEx by Fronteer, all drill samples were collected following standard industry practice and assayed by ALS Chemex of Reno, Nevada. Gold results were determined using standard fire assay techniques on a 30 gram sample with an atomic absorption finish. Samples exceeding 5 grams per tonne gold were re-assayed using a gravimetric finish and the values received were reported in the averages. QA/QC included the insertion of numerous standards and blanks into the sample stream, and a check assaying program that is underway at another laboratory. A table containing all drill results to date using a 0.3 gram/tonne cutoff is posted on the Company’s website. All data, as reported to the Company by Fronteer and disclosed in this press release, including sampling, analytical and test data, have been reviewed by the Company’s qualified person Mr. Eric M. Struhsacker, M.Sc., and Certified Professional Geologist as recognized by the American Institute of Professional Geologists. Further details concerning the Long Canyon property are described in the Company’s National Instrument 43-101 report filed on Sedar and posted on the Company’s website at www.auex.com.

AuEx Ventures, Inc. is a TSX listed precious metals exploration company that has a current portfolio of twenty one exploration projects in Nevada, one project in Spain and three projects in Argentina. The Company controls about 167,000 acres of unpatented mining claims and fee land in Nevada. Ten of the projects are in joint venture or exploration earn-in agreements with six companies. The Company applies the extensive Nevada exploration experience and high-end technical skills of its founders to search for and acquire new precious metal exploration projects that are then offered for joint venture.

AuEx Ventures, Inc.

Ronald L. Parratt, President and CEO

This release includes certain statements that may be deemed to be “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements in this release, other than statements of historical facts, that address future production, reserve potential, exploration and development activities and events or developments that the Company expects, are forward-looking statements. Although the management of AuEx believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see our public filings at www.sedar.com for further information. This press release uses the terms “indicated resources” and “inferred resources”, which are calculated in accordance with the Canadian National Instrument 43-101 and the Canadian Institute of Mining and Metallurgy Classification system. We advise investors that while those terms are recognized and required by Canadian regulations, the U.S. Securities and Exchange Commission does not recognize them. U.S. investors are cautioned not to assume that any part or all of mineral deposits in these categories will ever be converted into reserves. In addition, “Inferred resources” have a great amount of uncertainty as to their existence, and great uncertainty as to their economic and legal feasibility. It cannot be assumed that all or any part of an Inferred Mineral Resource will ever be upgraded to a higher category. Under Canadian rules, estimates of Inferred Mineral Resources may not form the basis of feasibility or pre-feasibility studies, except in rare cases. U.S. investors are cautioned not to assume that part or all of an inferred resource exists, or is economically or legally minable.

---------------------------------------------------------------------------
Inter-                               Inter-
cept                                 cept
From     To  Length      Au     From        To    Length     Au
Hole ID    (feet) (feet)  (feet)   oz/T  (meters)  (meters)  (meters)  (gpt)
---------------------------------------------------------------------------
LCM21         92    115      23   0.026       28      35.1       7.0   0.90
---------------------------------------------------------------------------
152    172      20   0.020     46.3      52.4       6.1   0.69
---------------------------------------------------------------------------
LCM22         42   61.5    19.5   0.017     12.8      18.8       5.9   0.58
---------------------------------------------------------------------------
87    217     130   0.145     26.5      66.2      39.6   4.97
---------------------------------------------------------------------------
including  151.5    172    20.5   0.489     46.2      52.4       6.3  16.76
---------------------------------------------------------------------------
LCM23        167    192      25   0.034     50.9      58.5       7.6   1.17
---------------------------------------------------------------------------
LCM24A      10.5     16     5.5   0.077      3.2       4.9       1.7   2.63
---------------------------------------------------------------------------
LCM24B         6     20      14   0.034      1.8       6.1       4.3   1.18
---------------------------------------------------------------------------
LCM24C         8   20.5    12.5   0.152      2.4       6.3       3.8   5.19
---------------------------------------------------------------------------
LCM24D       5.5   34.5      29   0.334      1.7      10.5       8.8  11.45
---------------------------------------------------------------------------
LCM24E       2.5   26.5      24   0.172      0.8       8.1       7.3   5.88
---------------------------------------------------------------------------
LCM25A       5.5   19.5      14   0.024      1.7       5.9       4.3   0.81
---------------------------------------------------------------------------
LCM25B       3.5   12.5       9   0.083      1.1       3.8       2.7   2.86
---------------------------------------------------------------------------
LCM25C       2.5   13.5      11   0.080      0.8       4.1       3.4   2.73
---------------------------------------------------------------------------
LCM25D         2   15.5    13.5   0.067      0.6       4.7       4.1   2.31
Tuesday, February 2nd, 2010 Uncategorized Comments Off on AuEx Ventures, Inc. (XAU) Final 2009 Long Canyon Holes Produce Strong Results

Enova (ENA) Secures United States General Services Administration (GSA) Exclusive Contract

Feb. 1, 2010 (Business Wire) — Enova Systems, Inc. (NYSE:ENA)(AIM:ENV)(AIM:ENVS), a leading innovator of proprietary hybrid and electric drive systems propelling the alternative energy industry, today announces the company has been awarded an exclusive supplier contract with the General Services Administration (GSA), which provides vehicles for government agencies and armed forces. The Enova Ze is powered by Enova’s 120kW all-electric drive system and is currently the only zero emissions solution for federal fleets in the step van category.

As part of the contract, Enova will supply Enova Ze all-electric walk-in step vans to GSA with a GVWR between 10,001 and 16,000 lbs. for 12, 14, and 16 foot body lengths. GSA, along with all Federal agencies, has been tasked by President Barack Obama in a recent Executive Order to set and meet specific targets for increased energy efficiency, a 30% reduction in fleet petroleum consumption, and reduced emissions by 2020.

The Enova Ze’s zero emissions technology has captured the attention of some of the largest commercial OEMs and fleet operators in the world. Recently, Enova has partnered with Freightliner Custom Chassis Corporation (FCCC), to integrate and deploy this innovative technology with the MT-45 walk-in van chassis, with deployment to national fleet operator(s) in the first quarter of 2010.

“Enova is honored to have been selected by GSA as the agency’s exclusive supplier of all-electric step vans,” says Enova President and CEO Michael Staran. “We are pleased that our technology has been recognized by the federal government and we are fully prepared to support GSA’s efforts to meet their targets as mandated by President Obama.”

“The Enova Ze is a perfect fit for U.S. government agency fleets that are looking to meet emissions targets. We continue to pave the way towards zero emissions commercial transportation and solidifying our position as a technology leader in this nascent government market,” says John Mullins, Enova’s Chief Operating Officer. “We encourage all government procurement officers to consider the road to reduced emissions with the Enova Ze.”

The U.S. Air Force has been evaluating the Ze all-electric drive system for more than 18 months, with positive results. Tom Quinn, the Director for the Hawaii Center for Advanced Transportation Technology (HCATT) says, “The Enova Ze has performed exceptionally well for the U.S. Air Force. The support staff at Hickam Air Force Base have relied on the Ze to deliver outstanding service and quiet performance every day. It certainly has become a valuable addition to their fleet.”

Advantages of the Ze drive system technology include:

  • Ease of use, with none of the maintenance requirements associated with gasoline drive trains.
  • 6 – 8 hour battery charge, achieved via a simple 220 volt outlet.
  • Combined Electronic Drive Motor (EDM), Enova Control Electronics Unit (CEU), and batteries eliminate the need for an internal combustion engine.
  • Ideal application for vehicles with a regular driving route that involves stop-and-go driving conditions.
  • Zero greenhouse gas emissions, making it an ideal candidate for government and commercial fleets looking to reduce their carbon footprints.

In related news, Enova lauded Smith Electric Vehicles’ (“Smith”) recent GSA announcement of the Smith Newton product offering in the Medium and Heavy Duty Vans category with a GVWR of 25,500 lbs. The Smith Newton is an exclusive, all-electric medium and heavy duty truck offering on the GSA product menu. Enova Systems is fulfilling orders of its drive system to Smith Electric Vehicles for both the UK and US initiatives, with shipments scheduled in 2010 in anticipation of orders for the Smith Newton.

Navistar continued to demonstrate its leadership in the American school bus market with its exclusive GSA contract to supply hybrid school buses. Enova is the exclusive supplier of hybrid electric drive systems to IC Bus, an affiliated division of Navistar. The Enova post-transmission hybrid drive technology couples a diesel engine with an 80 kW drive train that incorporates a control unit, a Li-ion battery pack and an electric motor.

“To achieve multi vehicle recognition from the GSA affirms Enova’s market leadership in the clean vehicle space. Such recognition will allow us to further expand the penetration of our drive system technology into government fleets as they consider their options in meeting President Obama’s order.” concluded Staran.

For further information, contact the Enova Systems GSA Hotline directly at (310) 527-2800 ext. 135.

About Enova

Enova Systems (NYSE:ENA and AIM:ENV and ENVS) is a leading supplier of efficient, environmentally friendly digital power components and systems products. The Company’s core competencies are focused on the development and commercialization of power management and conversion systems for mobile applications. Enova applies unique “enabling technologies” in the areas of alternative energy propulsion systems for light and heavy-duty vehicles as well as power conditioning and management systems for distributed generation systems. The Company develops, designs and produces non-invasive drive systems and related components for electric, hybrid-electric, and fuel cell powered vehicles in both the “new” and “retrofit” vehicle sales market. For further information, contact Enova Systems directly, or visit www.enovasystems.com. GSA Contract No. GS-30F-W0027

About GSA

The U.S. General Services Administration (GSA) is a mandatory source for vehicles under Federal Property Management Regulation 101-26.501 that purchases vehicles at a savings from the manufacturer’s list price. Purchasing at savings guarantees that government agencies receive the best value at the lowest possible price without having to go through a tedious bid process. For more information, visit www.gsa.gov.

About Freightliner Custom Chassis

Freightliner Custom Chassis Corporation manufactures premium chassis for the motor-home, delivery walk-in van, and school bus and shuttle bus markets. Freightliner Custom Chassis Corporation is a subsidiary of Daimler Trucks North America LLC, a Daimler company. For more information, visit www.freightlinerchassis.com.

Additional Information:

This news release contains forward-looking statements relating to Enova Systems and its products that are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward-looking terminology such as “believe,” “expect,” “may,” “will,” “should,” “could,” “project,” “plan,” “seek,” “intend,” or “anticipate” or the negative thereof or comparable terminology and statements about industry trends and Enova’s future performance, operations and products. These forward-looking statements are subject to and qualified by certain risks and uncertainties. These and other risks and uncertainties are detailed from time to time in Enova Systems’ periodic filings with the Securities and Exchange Commission, including but not limited to Enova’s annual report on Form 10-K for the year ended December 31, 2008.

Tuesday, February 2nd, 2010 Uncategorized Comments Off on Enova (ENA) Secures United States General Services Administration (GSA) Exclusive Contract

Conolog (CNLG) Announces Advance Orders for 280 Systems and Other Equipment

Feb. 1, 2010 (Business Wire) — Conolog Corporation (NASDAQ: CNLG), an engineering and design company that provides digital signal processing solutions to global electric utilities, announced today receiving advance orders for its PDR systems and other communication equipment valued at over $1,900,000 with deliveries to be scheduled over the next fiscal year.

Chairman of Conolog Robert Benou stated, “We are gratified that our new products and legacy components are increasing in demand.”

Benou added, “The Company will continue to control its production efforts and look forward to the production and marketing of our ‘Glow Worm’ and the design and introduction of the CM100 Multiplexer.”

About Conolog Corporation

Conolog Corporation is a provider of digital signal processing and digital security solutions to electric utilities worldwide. The Company designs and manufactures electromagnetic products to the military and provides engineering and design services to a variety of industries, government organizations and public utilities nationwide. The Company’s INIVEN division manufactures a line of digital signal processing systems, including transmitters, receivers and multiplexers.

Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products introduced by competitors, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission. There can be no assurance that utilities will purchase any of our systems.

Tuesday, February 2nd, 2010 Uncategorized Comments Off on Conolog (CNLG) Announces Advance Orders for 280 Systems and Other Equipment